The Healthcare sector includes companies that provide medical services, manufacture medical equipment and drugs, and develop biotechnologies and healthcare solutions. This sector spans a wide range of industries, from pharmaceutical companies and biotechnology firms to healthcare providers, hospitals, and medical device manufacturers. The healthcare sector is considered defensive, as demand for medical care remains constant regardless of the economic environment. Examples include pharmaceutical companies, medical device manufacturers, and healthcare providers.
Sector Read
Coverage Overview
A quick read on breadth, benchmark scope, and data participation.
Median pillar scores with the sector middle band for a quick read on quality, resilience, and valuation posture. Based on 2025.
Growth
Sample 325
Profitability
Sample 325
Health
Sample 325
Efficiency
Sample 325
Valuation
Sample 321
Distribution bands and center points across 1266 contributing companies. Use the tooltip for quartiles, completeness, and freshness, then compare those norms against the leaderboard cards below.
Trend highlights are prioritised around Cash Runway, Operating Margin for this sector.
Latest composite and moat snapshots, plus two sector-relevant benchmark metrics chosen for Healthcare. Tracking Cash Runway and Operating Margin.
Scan scale, positioning, and latest annual metric momentum across the sector without leaving the benchmark view.
| Company | Market Cap | Positioning |
Cash Runway
Latest annual + YoY
|
Operating Margin
Latest annual + YoY
|
|---|---|---|---|---|
|
1.14T
|
Composite
63.1
Moat
76.7
|
-
No YoY
|
45.6%
+7.7
YoY
|
|
|
623.71B
|
Composite
48.0
Moat
79.9
|
-
No YoY
|
27.2%
+3.2
YoY
|
|
|
ABBV
AbbVie Inc.
|
441.54B
|
Composite
40.8
Moat
68.7
|
-
No YoY
|
32.9%
+11.7
YoY
|
|
392.03B
|
Composite
59.8
Moat
52.1
|
-
No YoY
|
4.2%
-3.8
YoY
|
|
|
308.90B
|
Composite
32.7
Moat
76.7
|
-
No YoY
|
34.0%
+2.5
YoY
|
|
|
NVS
Novartis AG
|
295.03B
|
Composite
50.9
Moat
79.7
|
-
No YoY
|
31.1%
+3.0
YoY
|
|
AZN
Astrazeneca PLC
|
276.48B
|
Composite
49.2
Moat
74.1
|
-
No YoY
|
22.7%
+3.7
YoY
|
|
NVO
Novo Nordisk A/S
|
218.25B
|
Composite
58.9
Moat
81.6
|
-
No YoY
|
41.3%
-2.9
YoY
|
|
AMGN
Amgen Inc.
|
196.25B
|
Composite
50.9
Moat
71.4
|
-
No YoY
|
24.7%
+3.0
YoY
|
|
194.99B
|
Composite
62.7
Moat
59.9
|
-
No YoY
|
18.2%
+0.2
YoY
|
|
|
167.41B
|
Composite
56.7
Moat
81.8
|
-
No YoY
|
39.7%
+2.9
YoY
|
|
|
164.43B
|
Composite
66.8
Moat
73.4
|
-
No YoY
|
18.2%
+1.9
YoY
|
|
|
145.76B
|
Composite
65.8
Moat
82.5
|
-
No YoY
|
29.3%
+1.2
YoY
|
|
|
138.71B
|
Composite
65.2
Moat
69.7
|
-
No YoY
|
19.1%
-1.3
YoY
|
|
|
PFE
Pfizer, Inc.
|
138.21B
|
Composite
46.1
Moat
65.8
|
-
No YoY
|
27.8%
+4.3
YoY
|
|
131.18B
|
Composite
51.3
Moat
40.1
|
-
No YoY
|
2.6%
-0.0
YoY
|
|
|
126.01B
|
Composite
71.9
Moat
81.0
|
149.0
No YoY
|
38.0%
+40.1
YoY
|
|
|
125.40B
|
Composite
69.1
Moat
74.4
|
-
No YoY
|
20.1%
-0.5
YoY
|
|
|
118.32B
|
Composite
47.4
Moat
76.9
|
-
No YoY
|
28.5%
+16.3
YoY
|
|
|
GSK
GSK plc
|
105.54B
|
Composite
46.0
Moat
74.2
|
-
No YoY
|
25.5%
+7.9
YoY
|
|
MDT
Medtronic plc.
|
105.46B
|
Composite
70.4
Moat
73.0
|
-
No YoY
|
18.8%
-0.7
YoY
|
|
SNY
Sanofi
|
104.33B
|
Composite
45.5
Moat
72.8
|
-
No YoY
|
20.5%
+0.4
YoY
|
|
97.04B
|
Composite
56.2
Moat
50.4
|
-
No YoY
|
1.6%
+0.3
YoY
|
|
|
91.29B
|
Composite
55.0
Moat
59.4
|
-
No YoY
|
4.1%
-1.0
YoY
|
|
|
90.73B
|
Composite
55.0
Moat
66.8
|
-
No YoY
|
15.8%
+0.9
YoY
|
|
|
77.19B
|
Composite
46.0
Moat
54.6
|
-
No YoY
|
3.0%
-0.4
YoY
|
|
|
70.90B
|
Composite
69.4
Moat
79.5
|
-
No YoY
|
25.8%
-2.3
YoY
|
|
|
66.87B
|
Composite
67.6
Moat
77.4
|
-
No YoY
|
19.8%
+1.9
YoY
|
|
|
COR
Cencora, Inc.
|
60.23B
|
Composite
62.3
Moat
52.0
|
-
No YoY
|
1.2%
+0.2
YoY
|
|
ARGX
argenx SE
|
56.71B
|
Composite
69.2
Moat
77.7
|
490.0
+399.2
YoY
|
25.4%
+26.2
YoY
|
|
54.75B
|
Composite
55.9
Moat
47.4
|
-
No YoY
|
1.0%
+0.1
YoY
|
|
|
52.59B
|
Composite
61.1
Moat
77.3
|
-
No YoY
|
27.0%
-0.2
YoY
|
|
|
52.48B
|
Composite
61.8
Moat
61.2
|
-
No YoY
|
10.3%
+0.1
YoY
|
|
|
HUM
Humana Inc.
|
47.76B
|
Composite
49.2
Moat
50.6
|
-
No YoY
|
1.1%
-0.3
YoY
|
|
44.06B
|
Composite
65.2
Moat
75.2
|
-
No YoY
|
31.6%
+2.7
YoY
|
|
|
HLN
Haleon plc
|
42.54B
|
Composite
66.2
Moat
70.8
|
-
No YoY
|
21.9%
+2.2
YoY
|
|
41.76B
|
Composite
74.6
Moat
74.9
|
3890.0
+3841.4
YoY
|
13.5%
+21.4
YoY
|
|
|
41.57B
|
Composite
56.9
Moat
64.1
|
-
No YoY
|
13.7%
-0.5
YoY
|
|
|
40.63B
|
Composite
47.9
Moat
44.7
|
27.08
-22.2
YoY
|
-42.1%
-34.8
YoY
|
|
|
NTRA
Natera, Inc.
|
40.37B
|
Composite
52.6
Moat
54.3
|
42.71
+17.7
YoY
|
-13.4%
-0.3
YoY
|
|
38.54B
|
Composite
61.6
Moat
64.6
|
-
No YoY
|
22.9%
+2.6
YoY
|
|
|
37.73B
|
Composite
65.3
Moat
69.5
|
-
No YoY
|
21.3%
-1.6
YoY
|
|
|
37.03B
|
Composite
58.7
Moat
70.4
|
-
No YoY
|
25.4%
-3.0
YoY
|
|
|
34.88B
|
Composite
64.2
Moat
63.4
|
-
No YoY
|
14.0%
-0.7
YoY
|
|
|
ONC
BeiGene, Ltd.
|
33.67B
|
Composite
72.4
Moat
77.5
|
224.2
+191.3
YoY
|
8.4%
+23.3
YoY
|
|
33.38B
|
Composite
44.9
Moat
40.7
|
-
No YoY
|
-0.2%
-2.1
YoY
|
|
|
RPRX
Royalty Pharma plc
|
33.38B
|
Composite
74.5
Moat
86.4
|
-
No YoY
|
65.6%
+8.5
YoY
|
|
ALC
Alcon Inc.
|
32.67B
|
Composite
61.0
Moat
72.0
|
-
No YoY
|
13.1%
-1.2
YoY
|
|
ZTS
Zoetis Inc.
|
31.48B
|
Composite
70.8
Moat
84.7
|
-
No YoY
|
38.0%
+1.4
YoY
|
|
VEEV
Veeva Systems Inc.
|
30.82B
|
Composite
70.8
Moat
86.0
|
-
No YoY
|
28.7%
+3.5
YoY
|
|
MRNA
Moderna, Inc.
|
30.38B
|
Composite
50.6
Moat
50.9
|
37.15
+9.1
YoY
|
-1.6%
-0.4
YoY
|
|
RMD
ResMed Inc.
|
30.07B
|
Composite
70.3
Moat
80.9
|
-
No YoY
|
32.8%
+3.2
YoY
|
|
29.43B
|
Composite
59.8
Moat
71.6
|
-
No YoY
|
13.4%
+0.0
YoY
|
|
|
BIIB
Biogen Inc.
|
29.37B
|
Composite
45.8
Moat
75.4
|
-
No YoY
|
25.0%
+1.4
YoY
|
|
ILMN
Illumina, Inc.
|
29.32B
|
Composite
62.6
Moat
72.8
|
-
No YoY
|
18.8%
+5.1
YoY
|
|
DXCM
DexCom, Inc.
|
28.18B
|
Composite
73.0
Moat
72.5
|
-
No YoY
|
19.6%
+4.7
YoY
|
|
26.48B
|
Composite
45.4
Moat
34.9
|
68.64
-1.2
YoY
|
-155.6%
-117.3
YoY
|
|
|
26.03B
|
Composite
64.3
Moat
58.8
|
82.06
No YoY
|
8.1%
+5.3
YoY
|
|
|
26.03B
|
Composite
57.1
Moat
69.2
|
-
No YoY
|
27.8%
-1.3
YoY
|
|
|
INSM
Insmed Incorporated
|
25.63B
|
Composite
59.3
Moat
54.9
|
18.35
-6.8
YoY
|
-1.6%
+0.5
YoY
|
|
25.27B
|
Composite
60.6
Moat
64.5
|
-
No YoY
|
20.7%
+0.3
YoY
|
|
|
INCY
Incyte Corporation
|
23.68B
|
Composite
73.9
Moat
82.7
|
-
No YoY
|
26.1%
+23.7
YoY
|
|
BNTX
BioNTech SE
|
23.51B
|
Composite
51.1
Moat
64.2
|
-
No YoY
|
-22.3%
+3.5
YoY
|
|
23.45B
|
Composite
70.0
Moat
84.8
|
-
No YoY
|
47.7%
-2.7
YoY
|
|
|
23.03B
|
Composite
65.5
Moat
60.3
|
-
No YoY
|
14.1%
+0.5
YoY
|
|
|
22.77B
|
Composite
60.9
Moat
56.5
|
-
No YoY
|
10.9%
+2.1
YoY
|
|
|
21.76B
|
Composite
39.4
Moat
59.7
|
78.04
+36.0
YoY
|
-44.5%
+15.5
YoY
|
|
|
21.05B
|
Composite
71.2
Moat
69.0
|
-
No YoY
|
18.6%
+1.0
YoY
|
|
|
20.03B
|
Composite
58.7
Moat
62.7
|
33.93
No YoY
|
-6.1%
+0.4
YoY
|
|
|
GMAB
Genmab A/S
|
19.13B
|
Composite
65.4
Moat
77.6
|
-
No YoY
|
33.6%
+1.1
YoY
|
|
VTRS
Viatris Inc.
|
19.03B
|
Composite
65.4
Moat
48.2
|
-
No YoY
|
1.8%
-3.1
YoY
|
|
18.15B
|
Composite
73.0
Moat
80.6
|
-
No YoY
|
22.2%
-2.5
YoY
|
|
|
17.81B
|
Composite
69.3
Moat
77.5
|
-
No YoY
|
16.1%
+2.0
YoY
|
|
|
17.68B
|
Composite
52.9
Moat
64.1
|
15.81
+0.1
YoY
|
-100.0%
-97.4
YoY
|
|
|
17.26B
|
Composite
68.5
Moat
71.9
|
-
No YoY
|
16.5%
-3.4
YoY
|
|
|
ASND
Ascendis Pharma A/S
|
17.11B
|
Composite
64.7
Moat
64.8
|
21.93
+11.7
YoY
|
-18.9%
+57.7
YoY
|
|
HOLX
Hologic, Inc.
|
16.97B
|
Composite
62.6
Moat
60.9
|
-
No YoY
|
19.1%
-4.0
YoY
|
|
15.59B
|
Composite
76.8
Moat
75.5
|
-
No YoY
|
12.1%
-5.7
YoY
|
|
|
15.29B
|
Composite
65.7
Moat
67.0
|
-
No YoY
|
21.1%
-0.1
YoY
|
|
|
14.91B
|
Composite
67.4
Moat
47.9
|
35.15
No YoY
|
2.3%
+1.2
YoY
|
|
|
DVA
DaVita Inc.
|
14.73B
|
Composite
54.5
Moat
62.4
|
-
No YoY
|
14.7%
-0.5
YoY
|
|
EXEL
Exelixis, Inc.
|
14.35B
|
Composite
72.8
Moat
82.8
|
-
No YoY
|
38.5%
+6.7
YoY
|
|
13.85B
|
Composite
53.6
Moat
72.5
|
-
No YoY
|
16.7%
-1.4
YoY
|
|
|
13.38B
|
Composite
71.6
Moat
75.2
|
-
No YoY
|
13.9%
-0.9
YoY
|
|
|
13.15B
|
Composite
55.1
Moat
57.0
|
-
No YoY
|
7.6%
-5.0
YoY
|
|
|
ICLR
ICON plc
|
12.93B
|
Composite
55.4
Moat
57.3
|
-
No YoY
|
12.3%
-1.8
YoY
|
|
12.91B
|
Composite
60.2
Moat
61.0
|
62.27
+37.9
YoY
|
-31.3%
-28.5
YoY
|
|
|
12.76B
|
Composite
63.4
Moat
67.8
|
-
No YoY
|
14.5%
-2.3
YoY
|
|
|
12.75B
|
Composite
57.0
Moat
59.7
|
41.49
+12.0
YoY
|
-26.5%
+38.9
YoY
|
|
|
12.72B
|
Composite
52.6
Moat
64.5
|
-
No YoY
|
9.3%
+1.7
YoY
|
|
|
RVTY
Revvity, Inc.
|
12.60B
|
Composite
60.1
Moat
66.1
|
-
No YoY
|
12.5%
-0.1
YoY
|
|
PEN
Penumbra, Inc.
|
12.51B
|
Composite
66.7
Moat
72.9
|
40.54
No YoY
|
13.5%
+6.3
YoY
|
|
12.30B
|
Composite
62.6
Moat
55.8
|
-
No YoY
|
5.3%
-0.3
YoY
|
|
|
12.09B
|
Composite
42.8
Moat
50.0
|
185.2
No YoY
|
1.7%
-2.5
YoY
|
|
|
ABVX
Abivax SA
|
12.08B
|
Composite
50.9
Moat
40.0
|
39.50
+28.3
YoY
|
-
No YoY
|
|
12.01B
|
Composite
55.4
Moat
25.3
|
26.51
-8.3
YoY
|
-90.2%
-42.6
YoY
|
|
|
11.83B
|
Composite
63.0
Moat
62.2
|
17.65
-13.8
YoY
|
11.9%
+181.1
YoY
|
|
|
11.79B
|
Composite
61.6
Moat
60.5
|
-
No YoY
|
14.9%
-7.2
YoY
|
|
|
11.59B
|
Composite
68.5
Moat
80.1
|
-
No YoY
|
12.7%
-3.9
YoY
|
|
|
11.35B
|
Composite
52.1
Moat
49.4
|
-
No YoY
|
1.6%
-2.6
YoY
|
|
|
11.25B
|
Composite
52.5
Moat
56.6
|
-
No YoY
|
10.0%
-0.9
YoY
|
|
|
TECH
Bio-Techne Corp
|
11.09B
|
Composite
72.0
Moat
77.0
|
-
No YoY
|
19.9%
-1.4
YoY
|
|
11.07B
|
Composite
77.0
Moat
80.4
|
71.91
+26.7
YoY
|
41.4%
+5.9
YoY
|
|
|
TEM
Tempus AI, Inc.
|
11.04B
|
Composite
47.8
Moat
35.2
|
41.54
+13.1
YoY
|
-19.9%
+79.8
YoY
|
|
11.01B
|
Composite
64.5
Moat
80.5
|
-
No YoY
|
17.7%
+1.7
YoY
|
|
|
PODD
Insulet Corporation
|
10.96B
|
Composite
69.4
Moat
73.4
|
139.2
No YoY
|
17.5%
+2.6
YoY
|
|
10.62B
|
Composite
55.9
Moat
69.1
|
119.6
+64.6
YoY
|
-40.5%
+26.9
YoY
|
|
|
10.56B
|
Composite
45.5
Moat
41.6
|
20.76
-11.9
YoY
|
-7.0%
+22.1
YoY
|
|
|
GMED
Globus Medical, Inc.
|
10.34B
|
Composite
72.9
Moat
73.6
|
-
No YoY
|
18.3%
+9.6
YoY
|
|
10.01B
|
Composite
61.9
Moat
72.2
|
38.52
+2.0
YoY
|
-
No YoY
|
|
|
10.01B
|
Composite
60.0
Moat
80.7
|
-
No YoY
|
5.9%
-14.4
YoY
|
|
|
NUVL
Nuvalent, Inc.
|
9.82B
|
Composite
59.3
Moat
68.7
|
59.82
-12.7
YoY
|
-
No YoY
|
|
9.79B
|
Composite
57.5
Moat
65.1
|
-
No YoY
|
8.4%
0.0
YoY
|
|
|
HSIC
Henry Schein, Inc.
|
9.48B
|
Composite
55.7
Moat
60.5
|
-
No YoY
|
5.8%
-0.0
YoY
|
|
MASI
Masimo Corporation
|
9.42B
|
Composite
63.0
Moat
62.2
|
-
No YoY
|
20.5%
+15.9
YoY
|
|
OSCR
Oscar Health, Inc.
|
9.40B
|
Composite
63.0
Moat
33.1
|
112.9
No YoY
|
-3.4%
-4.0
YoY
|
|
9.40B
|
Composite
60.6
Moat
74.2
|
-
No YoY
|
11.5%
+0.8
YoY
|
|
|
9.39B
|
Composite
54.7
Moat
51.2
|
43.71
+13.6
YoY
|
-8.8%
-3.4
YoY
|
|
|
9.33B
|
Composite
75.2
Moat
79.6
|
-
No YoY
|
57.5%
+3.1
YoY
|
|
|
IBRX
ImmunityBio, Inc.
|
9.29B
|
Composite
47.7
Moat
60.8
|
9.56
+5.0
YoY
|
-2.3%
+21.1
YoY
|
|
9.29B
|
Composite
45.0
Moat
32.9
|
28.88
-6.9
YoY
|
-23.4%
+28.2
YoY
|
|
|
BRKR
Bruker Corporation
|
9.22B
|
Composite
62.8
Moat
52.3
|
-
No YoY
|
6.9%
-4.4
YoY
|
|
GKOS
Glaukos Corporation
|
9.10B
|
Composite
57.7
Moat
47.1
|
226.2
+163.8
YoY
|
-39.3%
-11.1
YoY
|
|
ALKS
Alkermes plc
|
8.96B
|
Composite
53.9
Moat
74.0
|
-
No YoY
|
17.2%
-9.8
YoY
|
|
8.89B
|
Composite
66.4
Moat
67.1
|
68.77
-23.3
YoY
|
20.0%
+7.3
YoY
|
|
|
8.85B
|
Composite
68.7
Moat
62.5
|
58.37
+32.0
YoY
|
-3.4%
-61.6
YoY
|
|
|
8.82B
|
Composite
56.1
Moat
33.6
|
32.64
-37.9
YoY
|
-67.1%
+259.0
YoY
|
|
|
QGEN
Qiagen N.V.
|
8.68B
|
Composite
60.4
Moat
68.0
|
-
No YoY
|
24.9%
+14.8
YoY
|
|
PCVX
Vaxcyte, Inc.
|
8.64B
|
Composite
54.5
Moat
50.2
|
28.57
-17.7
YoY
|
-
No YoY
|
|
8.58B
|
Composite
57.9
Moat
30.3
|
53.64
+7.7
YoY
|
-145.1%
-108.7
YoY
|
|
|
IMVT
Immunovant, Inc.
|
8.44B
|
Composite
51.1
Moat
62.1
|
26.58
+3.8
YoY
|
-
No YoY
|
|
8.28B
|
Composite
50.9
Moat
68.1
|
-
No YoY
|
8.5%
-2.0
YoY
|
|
|
RGEN
Repligen Corporation
|
8.12B
|
Composite
61.9
Moat
56.5
|
-
No YoY
|
5.6%
+10.7
YoY
|
|
ATR
AptarGroup, Inc.
|
7.94B
|
Composite
61.4
Moat
65.4
|
-
No YoY
|
13.5%
-0.7
YoY
|
|
7.93B
|
Composite
70.3
Moat
79.9
|
-
No YoY
|
24.9%
+8.0
YoY
|
|
|
7.91B
|
Composite
56.5
Moat
55.1
|
40.35
+6.6
YoY
|
-1.0%
+1.0
YoY
|
|
|
7.79B
|
Composite
53.0
Moat
69.9
|
48.43
+33.3
YoY
|
-4.2%
+21.8
YoY
|
|
|
7.60B
|
Composite
44.0
Moat
68.1
|
-
No YoY
|
8.5%
-2.0
YoY
|
|
|
MTSR
Metsera, Inc.
|
7.43B
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
7.43B
|
Composite
59.3
Moat
76.8
|
127.0
+60.6
YoY
|
49.5%
+67.7
YoY
|
|
|
LQDA
Liquidia Corporation
|
7.24B
|
Composite
81.0
Moat
59.9
|
64.12
+41.5
YoY
|
-32.5%
-23.8
YoY
|
|
AVTR
Avantor, Inc.
|
7.18B
|
Composite
52.5
Moat
55.3
|
-
No YoY
|
8.3%
-1.1
YoY
|
|
6.94B
|
Composite
56.0
Moat
54.9
|
14.70
-11.4
YoY
|
-4.0%
+2.9
YoY
|
|
|
PACS
PACS Group, Inc.
|
6.94B
|
Composite
57.8
Moat
49.5
|
-
No YoY
|
5.9%
+2.8
YoY
|
|
6.92B
|
Composite
57.3
Moat
49.6
|
40.88
+24.3
YoY
|
-
No YoY
|
|
|
6.90B
|
Composite
66.7
Moat
67.9
|
-
No YoY
|
20.5%
-8.8
YoY
|
|
|
6.86B
|
Composite
52.6
Moat
43.1
|
23.60
-17.9
YoY
|
-49.7%
-36.1
YoY
|
|
|
ACLX
Arcellx, Inc.
|
6.75B
|
Composite
50.3
Moat
40.3
|
25.70
-58.7
YoY
|
-11.4%
-10.1
YoY
|
|
CHE
Chemed Corp
|
6.48B
|
Composite
56.4
Moat
74.7
|
-
No YoY
|
13.5%
-1.6
YoY
|
|
CGON
CG Oncology, Inc.
|
6.47B
|
Composite
53.6
Moat
37.7
|
67.29
-45.8
YoY
|
-47.2%
+53.5
YoY
|
|
6.39B
|
Composite
66.1
Moat
82.6
|
-
No YoY
|
17.6%
+3.8
YoY
|
|
|
6.27B
|
Composite
56.4
Moat
51.8
|
18.24
-22.5
YoY
|
-13.8%
+11.1
YoY
|
|
|
6.11B
|
Composite
56.2
Moat
68.1
|
148.8
+87.4
YoY
|
-49.9%
No YoY
|
|
|
ERAS
Erasca, Inc.
|
5.96B
|
Composite
55.8
Moat
66.9
|
34.71
+2.0
YoY
|
-
No YoY
|
|
5.94B
|
Composite
56.3
Moat
64.0
|
233.6
No YoY
|
3.7%
-0.6
YoY
|
|
|
5.93B
|
Composite
54.8
Moat
58.5
|
-
No YoY
|
12.8%
-2.1
YoY
|
|
|
5.83B
|
Composite
42.9
Moat
47.8
|
58.56
+6.8
YoY
|
-36.2%
+20.0
YoY
|
|
|
BLTE
Belite Bio, Inc
|
5.80B
|
Composite
56.9
Moat
48.5
|
159.8
+100.2
YoY
|
-
No YoY
|
|
CELC
Celcuity Inc.
|
5.54B
|
Composite
49.4
Moat
51.2
|
34.56
+0.8
YoY
|
-
No YoY
|
|
5.47B
|
Composite
58.6
Moat
48.4
|
306.9
+153.4
YoY
|
-17.2%
+14.6
YoY
|
|
|
5.47B
|
Composite
56.2
Moat
40.5
|
37.59
-4.7
YoY
|
-87.4%
-71.1
YoY
|
|
|
5.44B
|
Composite
64.1
Moat
70.2
|
18.73
-5.6
YoY
|
-12.8%
-11.4
YoY
|
|
|
5.43B
|
Composite
47.0
Moat
42.8
|
68.72
-91.3
YoY
|
-13.3%
+46.8
YoY
|
|
|
5.43B
|
Composite
51.0
Moat
56.0
|
-
No YoY
|
13.2%
+0.7
YoY
|
|
|
5.39B
|
Composite
59.5
Moat
63.5
|
-
No YoY
|
16.8%
+2.2
YoY
|
|
|
ORKA
ARCA biopharma Inc
|
5.32B
|
Composite
59.4
Moat
61.8
|
45.85
-32.1
YoY
|
-
No YoY
|
|
5.30B
|
Composite
61.2
Moat
66.7
|
113.6
+20.1
YoY
|
-13.3%
+36.1
YoY
|
|
|
5.25B
|
Composite
65.0
Moat
72.3
|
56.17
+49.1
YoY
|
5.5%
+26.6
YoY
|
|
|
5.20B
|
Composite
55.1
Moat
65.4
|
44.23
-7.5
YoY
|
-
No YoY
|
|
|
RDNT
RadNet, Inc.
|
5.16B
|
Composite
62.3
Moat
55.2
|
-
No YoY
|
4.1%
-2.0
YoY
|
|
INDV
Indivior PLC
|
5.04B
|
Composite
57.5
Moat
62.6
|
86.67
+70.3
YoY
|
21.4%
+1.7
YoY
|
|
GRFS
Grifols, S.A.
|
5.03B
|
Composite
37.5
Moat
63.5
|
4879.4
No YoY
|
16.6%
+0.6
YoY
|
|
4.98B
|
Composite
70.5
Moat
60.1
|
17.31
No YoY
|
11.4%
+22.2
YoY
|
|
|
4.98B
|
Composite
61.4
Moat
74.7
|
24.08
No YoY
|
31.1%
+4.1
YoY
|
|
|
4.78B
|
Composite
44.6
Moat
45.2
|
30.39
-93.0
YoY
|
-5203.4%
No YoY
|
|
|
VCYT
Veracyte, Inc.
|
4.73B
|
Composite
63.5
Moat
73.1
|
67.23
No YoY
|
15.1%
+10.8
YoY
|
|
4.55B
|
Composite
67.6
Moat
72.8
|
88.50
+38.8
YoY
|
5.4%
-1.0
YoY
|
|
|
LIVN
LivaNova PLC
|
4.53B
|
Composite
65.7
Moat
71.9
|
-
No YoY
|
14.4%
+4.1
YoY
|
|
4.52B
|
Composite
69.6
Moat
77.5
|
43.86
-5.9
YoY
|
9.8%
+1.0
YoY
|
|
|
4.52B
|
Composite
52.4
Moat
48.9
|
28.26
-9.4
YoY
|
-19.7%
+18.8
YoY
|
|
|
4.45B
|
Composite
70.5
Moat
75.7
|
-
No YoY
|
22.7%
+9.6
YoY
|
|
|
4.41B
|
Composite
58.2
Moat
64.9
|
29.65
+6.1
YoY
|
-1.8%
+1.7
YoY
|
|
|
4.35B
|
Composite
55.0
Moat
42.9
|
64.64
-43.5
YoY
|
0.4%
+4.1
YoY
|
|
|
4.32B
|
Composite
56.6
Moat
66.1
|
25.24
-3.5
YoY
|
-59.5%
-56.4
YoY
|
|
|
4.24B
|
Composite
58.9
Moat
68.5
|
-
No YoY
|
12.2%
+0.7
YoY
|
|
|
4.20B
|
Composite
54.5
Moat
48.4
|
51.66
-11.5
YoY
|
-10.0%
-6.2
YoY
|
|
|
4.19B
|
Composite
52.3
Moat
63.1
|
-
No YoY
|
8.7%
+3.2
YoY
|
|
|
4.19B
|
Composite
60.1
Moat
47.6
|
56.02
No YoY
|
1.7%
+4.2
YoY
|
|
|
PINC
Premier, Inc.
|
4.13B
|
Composite
51.2
Moat
55.3
|
-
No YoY
|
0.1%
-11.0
YoY
|
|
DOCS
Doximity, Inc.
|
4.03B
|
Composite
70.4
Moat
84.6
|
-
No YoY
|
33.3%
-7.0
YoY
|
|
4.02B
|
Composite
58.5
Moat
68.5
|
-
No YoY
|
15.4%
-0.6
YoY
|
|
|
4.01B
|
Composite
51.0
Moat
51.0
|
33.05
+6.7
YoY
|
-
No YoY
|
|
|
3.99B
|
Composite
67.1
Moat
63.4
|
65.64
+50.8
YoY
|
2.2%
-8.5
YoY
|
|
|
3.92B
|
Composite
60.4
Moat
65.3
|
78.10
-12.8
YoY
|
-
No YoY
|
|
|
ICUI
ICU Medical, Inc.
|
3.91B
|
Composite
56.7
Moat
53.3
|
41.14
No YoY
|
4.9%
+0.8
YoY
|
|
3.87B
|
Composite
61.1
Moat
61.6
|
32.04
-79.1
YoY
|
-7.1%
+12.3
YoY
|
|
|
3.85B
|
Composite
71.2
Moat
83.7
|
-
No YoY
|
43.8%
+4.1
YoY
|
|
|
3.81B
|
Composite
51.3
Moat
55.9
|
24.42
-44.6
YoY
|
-1.6%
-0.4
YoY
|
|
|
ALMS
Alumis Inc.
|
3.79B
|
Composite
47.3
Moat
31.2
|
10.02
-3.5
YoY
|
-18.9%
No YoY
|
|
3.65B
|
Composite
37.5
Moat
42.4
|
67.13
No YoY
|
2.7%
+0.9
YoY
|
|
|
3.64B
|
Composite
56.7
Moat
57.2
|
78.97
+27.6
YoY
|
-
No YoY
|
|
|
3.60B
|
Composite
70.3
Moat
66.3
|
471.4
+447.0
YoY
|
-3.2%
+62.1
YoY
|
|
|
WRBY
Warby Parker Inc.
|
3.60B
|
Composite
60.3
Moat
55.3
|
96.17
No YoY
|
-0.6%
+3.3
YoY
|
|
3.57B
|
Composite
55.4
Moat
56.5
|
43.30
+13.9
YoY
|
-2.7%
+3.8
YoY
|
|
|
3.54B
|
Composite
58.1
Moat
62.1
|
107.9
+75.1
YoY
|
-72.8%
-26.1
YoY
|
|
|
OGN
Organon & Co.
|
3.54B
|
Composite
36.5
Moat
59.9
|
-
No YoY
|
19.7%
-3.5
YoY
|
|
3.50B
|
Composite
57.5
Moat
48.2
|
-
No YoY
|
1.6%
+0.6
YoY
|
|
|
3.49B
|
Composite
63.0
Moat
69.5
|
59.23
+31.2
YoY
|
-20.6%
+66.2
YoY
|
|
|
3.41B
|
Composite
60.0
Moat
67.8
|
-
No YoY
|
18.1%
+3.3
YoY
|
|
|
3.40B
|
Composite
47.5
Moat
62.1
|
-
No YoY
|
6.0%
-0.5
YoY
|
|
|
3.40B
|
Composite
54.5
Moat
63.5
|
17.51
-0.2
YoY
|
-79.5%
+16.2
YoY
|
|
|
3.31B
|
Composite
59.6
Moat
70.1
|
-
No YoY
|
8.5%
+1.5
YoY
|
|
|
GRAL
GRAIL, Inc.
|
3.25B
|
Composite
38.6
Moat
38.1
|
36.30
+20.4
YoY
|
-3.6%
+2.5
YoY
|
|
3.13B
|
Composite
63.5
Moat
54.7
|
56.09
-1.4
YoY
|
-
No YoY
|
|
|
3.09B
|
Composite
62.7
Moat
61.9
|
-
No YoY
|
12.9%
+0.1
YoY
|
|
|
3.06B
|
Composite
49.0
Moat
28.5
|
29.50
-25.7
YoY
|
-186.0%
-158.2
YoY
|
|
|
3.05B
|
Composite
48.6
Moat
46.8
|
35.57
-21.5
YoY
|
-
No YoY
|
|
|
3.01B
|
Composite
44.2
Moat
42.2
|
23.87
-4.1
YoY
|
-
No YoY
|
|
|
IRON
Disc Medicine, Inc.
|
3.00B
|
Composite
56.6
Moat
54.5
|
52.63
-10.0
YoY
|
-
No YoY
|
|
2.89B
|
Composite
50.8
Moat
58.4
|
-
No YoY
|
11.7%
-4.8
YoY
|
|
|
2.83B
|
Composite
69.3
Moat
58.6
|
-
No YoY
|
-5.1%
-16.6
YoY
|
|
|
2.76B
|
Composite
74.9
Moat
80.9
|
50.61
-31.0
YoY
|
7.8%
No YoY
|
|
|
2.76B
|
Composite
65.8
Moat
66.3
|
402.2
+360.0
YoY
|
-15.7%
+50.2
YoY
|
|
|
QURE
uniQure N.V.
|
2.74B
|
Composite
55.0
Moat
42.2
|
41.98
+17.8
YoY
|
-11.7%
-4.9
YoY
|
|
IMNM
Immunome, Inc.
|
2.74B
|
Composite
54.2
Moat
40.3
|
41.07
+17.5
YoY
|
-32.3%
-15.3
YoY
|
|
2.72B
|
Composite
52.4
Moat
70.7
|
74.01
+25.0
YoY
|
39.0%
+39.5
YoY
|
|
|
2.69B
|
Composite
63.9
Moat
56.9
|
55.33
+41.0
YoY
|
-
No YoY
|
|
|
2.61B
|
Composite
50.4
Moat
55.4
|
17.82
-0.7
YoY
|
-18.5%
+11.6
YoY
|
|
|
2.61B
|
Composite
52.0
Moat
46.7
|
53.67
+19.9
YoY
|
-
No YoY
|
|
|
ASTH
Astrana Health Inc.
|
2.61B
|
Composite
53.8
Moat
43.1
|
-
No YoY
|
2.5%
-1.9
YoY
|
|
2.60B
|
Composite
52.8
Moat
58.2
|
-
No YoY
|
5.0%
+10.1
YoY
|
|
|
2.55B
|
Composite
50.6
Moat
58.4
|
28.52
-13.9
YoY
|
-3.4%
+0.5
YoY
|
|
|
2.54B
|
Composite
52.3
Moat
53.6
|
27.49
-0.0
YoY
|
-8.7%
+2.9
YoY
|
|
|
BHVN
Biohaven Ltd.
|
2.53B
|
Composite
54.6
Moat
19.8
|
6.28
-3.7
YoY
|
-
No YoY
|
|
2.51B
|
Composite
60.2
Moat
33.7
|
30.35
+25.6
YoY
|
-31.9%
-29.4
YoY
|
|
|
PHVS
Pharvaris N.V.
|
2.51B
|
Composite
52.9
Moat
44.8
|
25.53
-2.5
YoY
|
-
No YoY
|
|
2.50B
|
Composite
46.5
Moat
27.4
|
18.52
+1.3
YoY
|
-
No YoY
|
|
|
2.49B
|
Composite
63.6
Moat
68.0
|
363.7
+311.0
YoY
|
17.9%
+9.4
YoY
|
|
|
VCEL
Vericel Corporation
|
2.47B
|
Composite
69.4
Moat
77.0
|
-
No YoY
|
4.0%
+2.1
YoY
|
|
2.46B
|
Composite
57.0
Moat
27.2
|
21.56
+2.0
YoY
|
-4.4%
-1.1
YoY
|
|
|
NKTR
Nektar Therapeutics
|
2.46B
|
Composite
55.8
Moat
60.9
|
14.14
-3.3
YoY
|
-2.4%
-1.0
YoY
|
|
PGNY
Progyny, Inc.
|
2.43B
|
Composite
64.8
Moat
65.7
|
-
No YoY
|
6.6%
+0.8
YoY
|
|
XRAY
DENTSPLY SIRONA Inc.
|
2.38B
|
Composite
48.2
Moat
53.7
|
-
No YoY
|
6.9%
+1.9
YoY
|
|
2.34B
|
Composite
66.8
Moat
78.6
|
-
No YoY
|
27.2%
+3.4
YoY
|
|
|
AXGN
AxoGen, Inc.
|
2.32B
|
Composite
57.5
Moat
61.4
|
65.13
+28.7
YoY
|
-3.5%
-1.7
YoY
|
|
2.31B
|
Composite
55.0
Moat
53.6
|
43.17
+8.2
YoY
|
-5.2%
-2.5
YoY
|
|
|
2.30B
|
Composite
64.5
Moat
75.0
|
-
No YoY
|
28.4%
-2.3
YoY
|
|
|
ZLAB
Zai Lab Limited
|
2.24B
|
Composite
55.0
Moat
63.0
|
54.88
+11.3
YoY
|
-48.6%
+20.1
YoY
|
|
2.23B
|
Composite
56.9
Moat
63.5
|
48.79
-20.4
YoY
|
-2.7%
+7.7
YoY
|
|
|
2.22B
|
Composite
59.7
Moat
64.6
|
51.02
-30.7
YoY
|
-80.8%
-79.1
YoY
|
|
|
2.20B
|
Composite
70.2
Moat
80.1
|
-
No YoY
|
24.0%
-2.7
YoY
|
|
|
2.20B
|
Composite
57.4
Moat
52.8
|
15.37
-10.1
YoY
|
-1.6%
+12.8
YoY
|
|
|
2.20B
|
Composite
48.4
Moat
66.5
|
-
No YoY
|
12.1%
+2.9
YoY
|
|
|
2.17B
|
Composite
63.1
Moat
63.8
|
54.88
-24.1
YoY
|
-29.9%
-41.4
YoY
|
|
|
2.16B
|
Composite
43.6
Moat
64.1
|
-
No YoY
|
14.2%
-0.4
YoY
|
|
|
2.16B
|
Composite
52.8
Moat
50.6
|
13.68
-7.0
YoY
|
-6.5%
+2.7
YoY
|
|
|
ADMA
ADMA Biologics Inc
|
2.15B
|
Composite
68.8
Moat
77.4
|
17.45
+12.0
YoY
|
37.5%
+4.9
YoY
|
|
2.14B
|
Composite
53.3
Moat
60.8
|
4.76
-27.5
YoY
|
10.7%
+3.7
YoY
|
|
|
2.13B
|
Composite
73.0
Moat
78.3
|
125.7
+66.9
YoY
|
37.6%
+29.8
YoY
|
|
|
NUVB
Nuvation Bio Inc.
|
2.13B
|
Composite
72.7
Moat
53.3
|
36.62
-9.6
YoY
|
-3.4%
+17.9
YoY
|
|
NEOG
Neogen Corporation
|
2.12B
|
Composite
51.9
Moat
49.7
|
-
No YoY
|
-0.2%
-6.5
YoY
|
|
2.10B
|
Composite
54.8
Moat
40.6
|
41.22
+20.7
YoY
|
-11.3%
-0.9
YoY
|
|
|
2.10B
|
Composite
50.8
Moat
46.3
|
142.2
+116.7
YoY
|
-88.5%
+2.2
YoY
|
|
|
2.08B
|
Composite
54.9
Moat
54.1
|
27.82
-64.7
YoY
|
-1.6%
No YoY
|
|
|
2.08B
|
Composite
47.6
Moat
47.9
|
37.97
+0.9
YoY
|
-5.1%
+985.1
YoY
|
|
|
OMCL
Omnicell, Inc.
|
2.07B
|
Composite
60.2
Moat
51.2
|
-
No YoY
|
0.4%
+0.4
YoY
|
|
2.07B
|
Composite
55.6
Moat
66.9
|
198.5
+134.8
YoY
|
-43.8%
-42.8
YoY
|
|
|
2.06B
|
Composite
44.1
Moat
58.9
|
59.45
+50.8
YoY
|
-3.1%
+4.5
YoY
|
|
|
2.05B
|
Composite
45.0
Moat
48.7
|
-
No YoY
|
6.2%
+1.0
YoY
|
|
|
2.04B
|
Composite
56.0
Moat
75.2
|
29.97
+0.2
YoY
|
-11.2%
-8.4
YoY
|
|
|
2.04B
|
Composite
54.8
Moat
48.4
|
30.84
+18.2
YoY
|
-2.9%
-13.1
YoY
|
|
|
2.03B
|
Composite
54.2
Moat
53.0
|
42.70
+9.2
YoY
|
-
No YoY
|
|
|
2.01B
|
Composite
63.0
Moat
54.6
|
67.29
+10.8
YoY
|
-
No YoY
|
|
|
NVCR
NovoCure Limited
|
2.00B
|
Composite
51.1
Moat
56.2
|
109.6
-327.3
YoY
|
-23.5%
+4.7
YoY
|
|
2.00B
|
Composite
47.0
Moat
43.9
|
23.99
+4.1
YoY
|
-8.7%
-0.5
YoY
|
|
|
1.98B
|
Composite
61.9
Moat
69.1
|
-
No YoY
|
9.7%
+0.8
YoY
|
|
|
NBTX
Nanobiotix S.A.
|
1.98B
|
Composite
49.1
Moat
59.1
|
18.94
-11.6
YoY
|
-36.5%
-42.4
YoY
|
|
ANAB
AnaptysBio, Inc.
|
1.97B
|
Composite
53.1
Moat
69.8
|
34.17
-4.7
YoY
|
20.4%
+21.7
YoY
|
|
PGEN
Precigen, Inc.
|
1.96B
|
Composite
54.4
Moat
34.9
|
13.37
-3.9
YoY
|
-11.0%
+13.1
YoY
|
|
1.96B
|
Composite
52.7
Moat
53.6
|
32.29
-26.4
YoY
|
-
No YoY
|
|
|
1.96B
|
Composite
50.0
Moat
38.9
|
29.92
+20.9
YoY
|
-27.7%
+304.0
YoY
|
|
|
1.96B
|
Composite
67.0
Moat
60.4
|
18.55
No YoY
|
9.2%
+8.8
YoY
|
|
|
1.95B
|
Composite
59.2
Moat
50.8
|
11.78
+0.8
YoY
|
-1.5%
+0.9
YoY
|
|
|
GLPG
Galapagos NV
|
1.95B
|
Composite
61.2
Moat
81.1
|
139.7
+22.8
YoY
|
45.1%
+113.4
YoY
|
|
1.95B
|
Composite
31.5
Moat
12.7
|
17.90
-21.1
YoY
|
-219.8%
-136.9
YoY
|
|
|
ABSI
Absci Corporation
|
1.94B
|
Composite
45.8
Moat
33.7
|
18.63
-0.0
YoY
|
-44.8%
-20.8
YoY
|
|
1.94B
|
Composite
55.7
Moat
49.8
|
253.8
+225.6
YoY
|
-6.5%
-0.1
YoY
|
|
|
1.93B
|
Composite
65.5
Moat
62.7
|
-
No YoY
|
15.4%
-1.3
YoY
|
|
|
MESO
Mesoblast Limited
|
1.91B
|
Composite
53.7
Moat
57.7
|
38.71
+23.2
YoY
|
-3.6%
+6.2
YoY
|
|
ZYME
Zymeworks Inc.
|
1.91B
|
Composite
51.6
Moat
69.3
|
83.19
+58.6
YoY
|
-87.3%
-85.8
YoY
|
|
1.90B
|
Composite
53.4
Moat
51.2
|
46.59
-32.0
YoY
|
-
No YoY
|
|
|
1.89B
|
Composite
32.0
Moat
40.7
|
114.4
+35.7
YoY
|
-3.5%
-0.6
YoY
|
|
|
GHRS
GH Research PLC
|
1.87B
|
Composite
51.7
Moat
58.2
|
77.34
+35.0
YoY
|
-
No YoY
|
|
1.87B
|
Composite
45.0
Moat
24.8
|
32.35
-50.7
YoY
|
-7.2%
-2.4
YoY
|
|
|
1.86B
|
Composite
50.4
Moat
28.9
|
23.90
-11.3
YoY
|
-21.1%
+11.6
YoY
|
|
|
1.85B
|
Composite
47.4
Moat
51.5
|
2551.2
+2471.5
YoY
|
-12.1%
+0.8
YoY
|
|
|
URGN
UroGen Pharma Ltd.
|
1.85B
|
Composite
54.4
Moat
59.6
|
8.90
-20.5
YoY
|
-1.1%
-0.1
YoY
|
|
1.84B
|
Composite
36.8
Moat
27.4
|
11.42
-5.2
YoY
|
-
No YoY
|
|
|
1.82B
|
Composite
46.3
Moat
63.1
|
9.30
No YoY
|
21.3%
+2.0
YoY
|
|
|
1.79B
|
Composite
60.2
Moat
38.1
|
33.29
+13.6
YoY
|
-56.2%
-38.0
YoY
|
|
|
1.77B
|
Composite
62.4
Moat
75.7
|
36.65
+32.6
YoY
|
34.4%
No YoY
|
|
|
1.75B
|
Composite
49.3
Moat
50.9
|
41.51
+22.9
YoY
|
-
No YoY
|
|
|
1.74B
|
Composite
48.3
Moat
48.8
|
14.30
-10.0
YoY
|
-7.2%
+1.5
YoY
|
|
|
ATRC
AtriCure, Inc.
|
1.71B
|
Composite
55.9
Moat
70.7
|
65.64
-38.1
YoY
|
-1.8%
+6.8
YoY
|
|
1.68B
|
Composite
61.0
Moat
71.0
|
968.1
+869.9
YoY
|
-11.3%
+11.4
YoY
|
|
|
1.67B
|
Composite
66.6
Moat
64.1
|
-
No YoY
|
-1.1%
+3.0
YoY
|
|
|
TDOC
Teladoc Health, Inc.
|
1.66B
|
Composite
53.2
Moat
47.4
|
-
No YoY
|
-6.5%
+1.7
YoY
|
|
1.66B
|
Composite
53.8
Moat
63.6
|
178.5
No YoY
|
3.0%
-0.1
YoY
|
|
|
1.65B
|
Composite
48.0
Moat
46.0
|
24.12
-22.0
YoY
|
-
No YoY
|
|
|
SEPN
Septerna, Inc.
|
1.64B
|
Composite
65.0
Moat
70.6
|
62.41
+35.0
YoY
|
-1.8%
+73.4
YoY
|
|
INVA
Innoviva, Inc.
|
1.64B
|
Composite
74.8
Moat
80.7
|
-
No YoY
|
39.8%
-6.7
YoY
|
|
1.61B
|
Composite
37.4
Moat
37.2
|
33.43
No YoY
|
-1.9%
+1.1
YoY
|
|
|
HROW
Harrow, Inc.
|
1.60B
|
Composite
47.7
Moat
61.6
|
25.54
No YoY
|
11.2%
+6.7
YoY
|
|
1.60B
|
Composite
53.8
Moat
50.3
|
25.19
-108.1
YoY
|
-2.1%
-5.8
YoY
|
|
|
1.57B
|
Composite
65.6
Moat
47.0
|
37.41
+5.1
YoY
|
-
No YoY
|
|
|
1.55B
|
Composite
44.8
Moat
62.2
|
142.7
No YoY
|
5.1%
-1.7
YoY
|
|
|
NVAX
Novavax, Inc.
|
1.55B
|
Composite
51.1
Moat
69.8
|
36.06
-90.9
YoY
|
49.0%
+85.5
YoY
|
|
1.54B
|
Composite
70.7
Moat
59.4
|
45.21
No YoY
|
-69.2%
-41.2
YoY
|
|
|
PSNL
Personalis, Inc.
|
1.53B
|
Composite
38.6
Moat
29.7
|
38.42
-10.8
YoY
|
-1.3%
+79.4
YoY
|
|
1.52B
|
Composite
41.7
Moat
18.6
|
11.48
+2.1
YoY
|
-103.9%
+1553.4
YoY
|
|
|
GLTO
Galecto, Inc.
|
1.49B
|
Composite
56.6
Moat
42.2
|
9.13
-1.6
YoY
|
-
No YoY
|
|
1.49B
|
Composite
71.8
Moat
69.5
|
23.24
+4.8
YoY
|
8.5%
+25.1
YoY
|
|
|
1.48B
|
Composite
63.2
Moat
75.5
|
-
No YoY
|
5.6%
+1.1
YoY
|
|
|
PRGO
Perrigo Company plc
|
1.44B
|
Composite
44.1
Moat
50.4
|
-
No YoY
|
7.3%
+0.2
YoY
|
|
1.44B
|
Composite
53.0
Moat
47.7
|
17.31
-11.0
YoY
|
-4.6%
No YoY
|
|
|
1.43B
|
Composite
61.5
Moat
47.3
|
-
No YoY
|
1.1%
-0.7
YoY
|
|
|
CDNA
CareDx, Inc.
|
1.42B
|
Composite
62.1
Moat
64.1
|
153.6
+14.3
YoY
|
-6.6%
+10.0
YoY
|
|
1.42B
|
Composite
50.4
Moat
60.8
|
37.31
+3.5
YoY
|
-7.6%
+12.5
YoY
|
|
|
1.41B
|
Composite
47.3
Moat
55.2
|
3.42
No YoY
|
5.4%
-0.0
YoY
|
|
|
1.40B
|
Composite
51.6
Moat
56.0
|
65.74
No YoY
|
-19.2%
-15.2
YoY
|
|
|
1.38B
|
Composite
56.3
Moat
60.1
|
42.42
-46.2
YoY
|
-17.3%
-11.3
YoY
|
|
|
1.37B
|
Composite
39.1
Moat
32.6
|
29.23
+3.6
YoY
|
-26.6%
-23.0
YoY
|
|
|
IMTX
Immatics N.V.
|
1.36B
|
Composite
51.8
Moat
58.3
|
31.89
-14.0
YoY
|
-3.8%
+21.0
YoY
|
|
1.36B
|
Composite
57.0
Moat
51.6
|
20.76
-3.8
YoY
|
-
No YoY
|
|
|
AHCO
AdaptHealth Corp.
|
1.35B
|
Composite
60.7
Moat
56.9
|
-
No YoY
|
5.7%
-2.8
YoY
|
|
ARDX
Ardelyx, Inc.
|
1.33B
|
Composite
60.5
Moat
67.9
|
74.77
+7.8
YoY
|
-10.1%
-1.7
YoY
|
|
1.31B
|
Composite
62.1
Moat
57.2
|
-
No YoY
|
8.5%
+3.3
YoY
|
|
|
SVRA
Savara, Inc.
|
1.31B
|
Composite
55.1
Moat
47.9
|
27.99
+1.5
YoY
|
-
No YoY
|
|
1.30B
|
Composite
57.3
Moat
50.4
|
54.68
+9.2
YoY
|
-1.9%
+93.7
YoY
|
|
|
1.29B
|
Composite
48.7
Moat
53.8
|
17.07
+5.2
YoY
|
-1.3%
+3.6
YoY
|
|
|
MNKD
MannKind Corporation
|
1.28B
|
Composite
60.1
Moat
73.0
|
25.41
-14.3
YoY
|
13.3%
-10.7
YoY
|
|
NUTX
Nutex Health Inc.
|
1.26B
|
Composite
67.5
Moat
71.2
|
-
No YoY
|
31.5%
+2.8
YoY
|
|
SDGR
Schrodinger, Inc.
|
1.25B
|
Composite
38.5
Moat
37.2
|
26.85
-13.8
YoY
|
-65.2%
-64.2
YoY
|
|
IRMD
iRadimed Corporation
|
1.25B
|
Composite
73.0
Moat
82.7
|
-
No YoY
|
31.2%
+1.2
YoY
|
|
1.24B
|
Composite
40.9
Moat
47.7
|
15.30
-20.0
YoY
|
-7.8%
-4.4
YoY
|
|
|
1.22B
|
Composite
62.9
Moat
38.8
|
-
No YoY
|
1.2%
-2.8
YoY
|
|
|
1.21B
|
Composite
61.1
Moat
48.9
|
38.53
+14.5
YoY
|
-5.0%
-4.0
YoY
|
|
|
XNCR
Xencor, Inc.
|
1.19B
|
Composite
49.9
Moat
64.8
|
48.65
+19.1
YoY
|
-1.4%
+0.2
YoY
|
|
1.19B
|
Composite
52.8
Moat
39.9
|
-
No YoY
|
2.0%
+0.4
YoY
|
|
|
ALVO
Alvotech
|
1.18B
|
Composite
47.2
Moat
49.5
|
41.20
+38.6
YoY
|
13.3%
-0.9
YoY
|
|
1.18B
|
Composite
54.3
Moat
35.8
|
11.55
+3.3
YoY
|
-
No YoY
|
|
|
AZTA
Azenta, Inc.
|
1.17B
|
Composite
38.5
Moat
63.3
|
40.43
No YoY
|
-3.6%
+3.3
YoY
|
|
1.17B
|
Composite
55.1
Moat
42.9
|
32.89
-3.3
YoY
|
-
No YoY
|
|
|
AORT
Artivion, Inc.
|
1.17B
|
Composite
60.6
Moat
65.1
|
91.64
-163.7
YoY
|
6.1%
-3.9
YoY
|
|
AVNS
Avanos Medical, Inc.
|
1.17B
|
Composite
57.5
Moat
56.7
|
-
No YoY
|
2.2%
-3.7
YoY
|
|
1.16B
|
Composite
67.0
Moat
68.9
|
-
No YoY
|
22.9%
-3.6
YoY
|
|
|
1.13B
|
Composite
59.2
Moat
60.6
|
30.44
+3.2
YoY
|
-
No YoY
|
|
|
1.13B
|
Composite
54.2
Moat
63.5
|
25.80
-7.1
YoY
|
-3.6%
No YoY
|
|
|
1.12B
|
Composite
50.2
Moat
50.6
|
70.19
+29.8
YoY
|
-33.7%
+9.3
YoY
|
|
|
1.12B
|
Composite
46.4
Moat
61.2
|
-
No YoY
|
10.3%
+0.5
YoY
|
|
|
BIOA
BioAge Labs, Inc.
|
1.11B
|
Composite
44.0
Moat
20.7
|
41.32
-41.2
YoY
|
-10.3%
No YoY
|
|
CNMD
CONMED Corporation
|
1.10B
|
Composite
62.8
Moat
63.8
|
-
No YoY
|
7.5%
-7.9
YoY
|
|
1.10B
|
Composite
55.0
Moat
46.7
|
14.42
-3.4
YoY
|
-12.3%
-7.0
YoY
|
|
|
KURA
Kura Oncology, Inc.
|
1.08B
|
Composite
52.7
Moat
49.4
|
125.0
+84.2
YoY
|
-4.5%
-0.9
YoY
|
|
1.07B
|
Composite
57.5
Moat
53.9
|
41.34
-8.6
YoY
|
-
No YoY
|
|
|
1.07B
|
Composite
50.2
Moat
65.6
|
38.28
+27.2
YoY
|
-
No YoY
|
|
|
CERT
Certara, Inc.
|
1.06B
|
Composite
60.7
Moat
63.4
|
-
No YoY
|
5.0%
+5.5
YoY
|
|
1.05B
|
Composite
58.9
Moat
46.9
|
361.3
+184.8
YoY
|
-16.5%
-5.9
YoY
|
|
|
1.05B
|
Composite
38.8
Moat
41.8
|
24.81
-3.4
YoY
|
-36.1%
+2.3
YoY
|
|
|
CVAC
CureVac N.V.
|
1.05B
|
Composite
67.8
Moat
72.5
|
18.15
-2.8
YoY
|
33.2%
+38.3
YoY
|
|
1.04B
|
Composite
60.2
Moat
44.1
|
241.4
+122.9
YoY
|
-13.3%
+37.3
YoY
|
|
|
1.02B
|
Composite
66.9
Moat
47.1
|
36.62
No YoY
|
-1.1%
+5.6
YoY
|
|
|
1.02B
|
Composite
56.4
Moat
50.3
|
141.0
-139.7
YoY
|
-15.8%
-6.4
YoY
|
|
|
1.02B
|
Composite
65.5
Moat
60.3
|
27.69
+5.0
YoY
|
-1.9%
+9.4
YoY
|
|
|
EVO
Evotec SE
|
1.01B
|
Composite
44.7
Moat
40.3
|
605.3
No YoY
|
-7.1%
+2.8
YoY
|
|
1.01B
|
Composite
37.4
Moat
42.3
|
26.41
+12.9
YoY
|
-29.6%
-19.4
YoY
|
|
|
PHAR
Pharming Group N.V.
|
1.01B
|
Composite
65.8
Moat
75.6
|
1122.4
+974.4
YoY
|
5.5%
+6.8
YoY
|
|
1.01B
|
Composite
45.8
Moat
29.5
|
22.93
-10.0
YoY
|
-1236.0%
-1143.3
YoY
|
|
|
1.00B
|
Composite
51.9
Moat
61.3
|
19.93
+1.8
YoY
|
-
No YoY
|
|
|
1.00B
|
Composite
60.5
Moat
60.4
|
-
No YoY
|
2.6%
-10.2
YoY
|
|
|
GERN
Geron Corporation
|
1.00B
|
Composite
65.2
Moat
61.9
|
38.68
+16.4
YoY
|
-28.0%
-25.8
YoY
|
|
999.40M
|
Composite
65.7
Moat
57.9
|
17.02
+1.0
YoY
|
-98.2%
-91.9
YoY
|
|
|
995.71M
|
Composite
57.5
Moat
71.3
|
-
No YoY
|
11.0%
+2.7
YoY
|
|
|
ANNX
Annexon, Inc.
|
973.22M
|
Composite
56.9
Moat
46.7
|
15.35
-16.4
YoY
|
-
No YoY
|
|
970.00M
|
Composite
55.8
Moat
43.1
|
42.57
+13.0
YoY
|
-43.2%
+14.2
YoY
|
|
|
965.87M
|
Composite
58.0
Moat
62.1
|
9.35
-4.0
YoY
|
-91.4%
-86.3
YoY
|
|
|
954.34M
|
Composite
56.2
Moat
66.2
|
48.53
-19.8
YoY
|
-
No YoY
|
|
|
952.10M
|
Composite
51.5
Moat
42.5
|
19.23
+15.5
YoY
|
-
No YoY
|
|
|
INMD
InMode Ltd.
|
951.01M
|
Composite
67.2
Moat
70.1
|
-
No YoY
|
23.1%
-5.4
YoY
|
|
936.00M
|
Composite
45.2
Moat
36.5
|
32.70
-44.1
YoY
|
-
No YoY
|
|
|
933.47M
|
Composite
48.6
Moat
40.9
|
11.51
-18.7
YoY
|
-
No YoY
|
|
|
923.78M
|
Composite
25.5
Moat
38.9
|
7.29
+3.5
YoY
|
24.4%
+53.4
YoY
|
|
|
896.79M
|
Composite
49.5
Moat
33.0
|
18.15
-4.6
YoY
|
-
No YoY
|
|
|
880.04M
|
Composite
67.5
Moat
82.4
|
91.91
+46.4
YoY
|
-3.4%
+62.6
YoY
|
|
|
TALK
Talkspace, Inc.
|
874.42M
|
Composite
49.9
Moat
46.1
|
90.70
+63.5
YoY
|
1.4%
+3.8
YoY
|
|
861.00M
|
Composite
56.6
Moat
66.5
|
21.76
+7.8
YoY
|
-29.3%
-47.4
YoY
|
|
|
NGNE
Neurogene Inc.
|
853.67M
|
Composite
46.3
Moat
25.9
|
41.83
-11.3
YoY
|
-89.3%
No YoY
|
|
838.65M
|
Composite
64.2
Moat
67.5
|
-
No YoY
|
19.5%
-8.6
YoY
|
|
|
BVS
Bioventus Inc.
|
827.88M
|
Composite
63.7
Moat
66.3
|
26.76
No YoY
|
9.9%
+5.9
YoY
|
|
827.32M
|
Composite
47.1
Moat
33.3
|
38.55
+14.3
YoY
|
-
No YoY
|
|
|
824.06M
|
Composite
69.8
Moat
70.9
|
1434.4
+1422.4
YoY
|
-4.0%
-0.3
YoY
|
|
|
822.04M
|
Composite
47.7
Moat
47.6
|
153.8
+80.4
YoY
|
14.9%
-1.4
YoY
|
|
|
HSTM
HealthStream, Inc.
|
818.61M
|
Composite
63.3
Moat
70.1
|
-
No YoY
|
6.7%
-0.6
YoY
|
|
809.65M
|
Composite
72.6
Moat
77.5
|
119.0
+109.5
YoY
|
42.6%
+29.1
YoY
|
|
|
RGNX
REGENXBIO Inc.
|
809.10M
|
Composite
49.1
Moat
57.1
|
22.27
+6.0
YoY
|
-94.6%
-91.8
YoY
|
|
797.48M
|
Composite
38.8
Moat
20.0
|
23.11
-44.8
YoY
|
-9.5%
-6.7
YoY
|
|
|
CLYM
Climb Bio, Inc.
|
791.34M
|
Composite
52.4
Moat
67.0
|
22.32
-94.1
YoY
|
-
No YoY
|
|
789.50M
|
Composite
50.2
Moat
39.5
|
50.35
+35.8
YoY
|
-
No YoY
|
|
|
785.21M
|
Composite
64.5
Moat
70.1
|
-
No YoY
|
40.1%
+12.9
YoY
|
|
|
782.51M
|
Composite
57.8
Moat
44.4
|
17.21
-29.0
YoY
|
-2.1%
+1.3
YoY
|
|
|
SIBN
SI-BONE, Inc.
|
772.56M
|
Composite
53.5
Moat
58.9
|
2628.0
+2483.1
YoY
|
-11.1%
+10.0
YoY
|
|
772.10M
|
Composite
55.4
Moat
47.1
|
20.43
-2.3
YoY
|
-
No YoY
|
|
|
764.81M
|
Composite
65.5
Moat
70.5
|
87.90
No YoY
|
9.9%
-5.5
YoY
|
|
|
PRME
Prime Medicine, Inc.
|
764.01M
|
Composite
46.2
Moat
38.7
|
13.12
-5.5
YoY
|
-45.0%
+22.9
YoY
|
|
CBLL
CeriBell, Inc.
|
745.19M
|
Composite
49.9
Moat
50.0
|
46.83
-19.7
YoY
|
-65.6%
-4.9
YoY
|
|
744.90M
|
Composite
42.1
Moat
65.7
|
518.5
+444.0
YoY
|
-12.4%
-15.1
YoY
|
|
|
OMER
Omeros Corporation
|
743.30M
|
Composite
56.8
Moat
46.9
|
17.76
+10.5
YoY
|
-
No YoY
|
|
BBNX
Beta Bionics, Inc.
|
732.15M
|
Composite
52.2
Moat
40.3
|
51.63
+25.9
YoY
|
-71.5%
-2.0
YoY
|
|
724.82M
|
Composite
49.1
Moat
28.6
|
20.12
+2.6
YoY
|
-11703.7%
-8393.3
YoY
|
|
|
724.64M
|
Composite
60.5
Moat
37.4
|
37.50
-8.1
YoY
|
-277.4%
-80.2
YoY
|
|
|
718.10M
|
Composite
49.7
Moat
68.9
|
48.49
+5.3
YoY
|
-
No YoY
|
|
|
EHAB
Enhabit, Inc.
|
706.56M
|
Composite
53.1
Moat
55.2
|
-
No YoY
|
6.0%
+1.5
YoY
|
|
700.02M
|
Composite
65.0
Moat
55.8
|
138.1
+25.3
YoY
|
-
No YoY
|
|
|
692.03M
|
Composite
61.8
Moat
71.1
|
-
No YoY
|
8.9%
+1.3
YoY
|
|
|
682.84M
|
Composite
70.1
Moat
50.4
|
24.38
+14.0
YoY
|
-
No YoY
|
|
|
CRMD
CorMedix Inc.
|
680.18M
|
Composite
76.1
Moat
74.7
|
12.25
-11.5
YoY
|
48.2%
+99.6
YoY
|
|
673.84M
|
Composite
56.6
Moat
55.2
|
44.30
+6.4
YoY
|
-1.9%
+5074.9
YoY
|
|
|
PHR
Phreesia, Inc.
|
668.80M
|
Composite
62.6
Moat
51.9
|
32.44
+8.9
YoY
|
-1.4%
+12.5
YoY
|
|
665.52M
|
Composite
50.9
Moat
45.1
|
50.69
+22.0
YoY
|
-
No YoY
|
|
|
663.93M
|
Composite
56.2
Moat
54.2
|
114.5
+77.4
YoY
|
-
No YoY
|
|
|
657.02M
|
Composite
55.6
Moat
26.6
|
8.83
-5.0
YoY
|
-
No YoY
|
|
|
635.61M
|
Composite
48.2
Moat
51.6
|
29.65
+8.6
YoY
|
-1.8%
+0.4
YoY
|
|
|
633.30M
|
Composite
47.3
Moat
37.9
|
195.5
No YoY
|
-1.1%
-0.5
YoY
|
|
|
CERS
Cerus Corporation
|
631.16M
|
Composite
57.6
Moat
57.1
|
18.31
-29.6
YoY
|
-4.2%
+3.7
YoY
|
|
MDXG
MiMedx Group, Inc
|
616.64M
|
Composite
62.1
Moat
77.8
|
44.23
-483.0
YoY
|
15.3%
-1.7
YoY
|
|
609.93M
|
Composite
43.9
Moat
38.2
|
12.43
-7.7
YoY
|
-
No YoY
|
|
|
ALT
Altimmune, Inc.
|
606.76M
|
Composite
52.5
Moat
32.2
|
48.59
+28.8
YoY
|
-2304.6%
+2854.0
YoY
|
|
BWAY
Brainsway Ltd.
|
606.60M
|
Composite
65.0
Moat
78.2
|
58.50
No YoY
|
8.3%
+4.9
YoY
|
|
598.67M
|
Composite
61.5
Moat
21.9
|
23.71
+5.6
YoY
|
-
No YoY
|
|
|
596.40M
|
Composite
54.8
Moat
50.0
|
21.80
-8.2
YoY
|
-4.2%
+0.5
YoY
|
|
|
593.01M
|
Composite
43.0
Moat
33.9
|
39.68
No YoY
|
-28.2%
-2.2
YoY
|
|
|
592.76M
|
Composite
46.1
Moat
46.3
|
669.7
+335.0
YoY
|
-20.0%
-9.8
YoY
|
|
|
MOVE
Movano Inc.
|
579.88M
|
Composite
37.5
Moat
15.9
|
3.01
-1.2
YoY
|
-35.8%
-11.9
YoY
|
|
NPCE
Neuropace, Inc.
|
578.57M
|
Composite
51.9
Moat
57.0
|
66.57
+31.3
YoY
|
-16.3%
+10.8
YoY
|
|
577.62M
|
Composite
60.5
Moat
83.5
|
57.04
-17.8
YoY
|
32.1%
No YoY
|
|
|
576.13M
|
Composite
40.7
Moat
61.5
|
141.2
+126.0
YoY
|
-8.2%
+2.3
YoY
|
|
|
561.80M
|
Composite
76.3
Moat
82.5
|
91.81
-9.6
YoY
|
97.6%
+101.5
YoY
|
|
|
ARVN
Arvinas, Inc.
|
551.01M
|
Composite
52.0
Moat
65.9
|
30.04
-18.1
YoY
|
-45.1%
+49.9
YoY
|
|
PROK
ProKidney Corp.
|
543.70M
|
Composite
47.4
Moat
39.0
|
26.98
-7.1
YoY
|
-184.8%
+2232.0
YoY
|
|
STTK
Shattuck Labs, Inc.
|
539.06M
|
Composite
55.3
Moat
44.5
|
23.49
+9.0
YoY
|
-51.5%
-37.4
YoY
|
|
538.66M
|
Composite
48.6
Moat
42.3
|
106.5
+26.4
YoY
|
-12.8%
+2.6
YoY
|
|
|
ANGO
AngioDynamics, Inc.
|
533.80M
|
Composite
41.0
Moat
51.7
|
66.22
+33.8
YoY
|
-8.2%
+2.9
YoY
|
|
531.91M
|
Composite
41.7
Moat
29.8
|
27.73
+3.7
YoY
|
-1.6%
+51.9
YoY
|
|
|
TLRY
Tilray Brands, Inc.
|
523.65M
|
Composite
47.1
Moat
35.3
|
32.52
-68.6
YoY
|
-13.1%
+1.2
YoY
|
|
ZURA
Zura Bio Limited
|
521.54M
|
Composite
58.5
Moat
44.3
|
20.26
-55.2
YoY
|
-
No YoY
|
|
521.40M
|
Composite
37.6
Moat
61.0
|
46.44
No YoY
|
8.7%
+2.0
YoY
|
|
|
518.50M
|
Composite
48.7
Moat
40.0
|
23.03
-3.9
YoY
|
-65.4%
-2.5
YoY
|
|
|
515.70M
|
Composite
72.0
Moat
44.4
|
22.56
-15.1
YoY
|
-19.1%
-17.9
YoY
|
|
|
512.91M
|
Composite
34.4
Moat
36.3
|
16.38
-6.1
YoY
|
-7.2%
+8.1
YoY
|
|
|
CABA
Cabaletta Bio, Inc.
|
507.92M
|
Composite
57.5
Moat
33.7
|
12.23
-10.1
YoY
|
-
No YoY
|
|
507.79M
|
Composite
59.8
Moat
46.7
|
22.00
+6.4
YoY
|
-8.6%
+11.3
YoY
|
|
|
507.54M
|
Composite
52.3
Moat
66.2
|
150.5
+120.0
YoY
|
-12.3%
+2.2
YoY
|
|
|
506.42M
|
Composite
52.1
Moat
54.1
|
10.65
-4.8
YoY
|
-2.5%
+4.9
YoY
|
|
|
500.07M
|
Composite
45.3
Moat
26.9
|
30.16
+7.5
YoY
|
-3.5%
-1.6
YoY
|
|
|
OCGN
Ocugen, Inc.
|
497.63M
|
Composite
51.2
Moat
34.1
|
3.91
-12.7
YoY
|
-14.3%
-0.8
YoY
|
|
496.95M
|
Composite
51.6
Moat
64.5
|
9.58
-10.3
YoY
|
-1.0%
+2.8
YoY
|
|
|
VALN
Valneva SE
|
495.80M
|
Composite
54.6
Moat
62.0
|
24.88
-5.2
YoY
|
-46.7%
-0.9
YoY
|
|
489.27M
|
Composite
61.2
Moat
70.8
|
-
No YoY
|
16.4%
-8.2
YoY
|
|
|
485.26M
|
Composite
58.9
Moat
49.8
|
21.80
+10.4
YoY
|
-5.9%
+103.5
YoY
|
|
|
RZLT
Rezolute, Inc.
|
477.60M
|
Composite
54.9
Moat
64.0
|
29.16
+2.6
YoY
|
-
No YoY
|
|
474.87M
|
Composite
61.6
Moat
51.6
|
29.74
-13.0
YoY
|
-15.4%
No YoY
|
|
|
VSTM
Verastem, Inc.
|
474.52M
|
Composite
54.9
Moat
38.7
|
18.66
+8.5
YoY
|
-5.5%
+6.0
YoY
|
|
474.33M
|
Composite
54.5
Moat
61.9
|
30.22
-14.9
YoY
|
-2.9%
+0.4
YoY
|
|
|
466.70M
|
Composite
63.4
Moat
67.5
|
34.20
+21.7
YoY
|
0.8%
+34.1
YoY
|
|
|
465.73M
|
Composite
48.0
Moat
24.4
|
16.40
-9.7
YoY
|
-160.6%
-159.1
YoY
|
|
|
465.40M
|
Composite
61.7
Moat
68.0
|
-
No YoY
|
7.7%
+0.5
YoY
|
|
|
464.61M
|
Composite
49.1
Moat
42.5
|
15.28
-42.7
YoY
|
-12.7%
-2.4
YoY
|
|
|
464.00M
|
Composite
50.5
Moat
59.4
|
8.68
-44.0
YoY
|
-10.0%
-0.3
YoY
|
|
|
463.10M
|
Composite
49.9
Moat
35.9
|
49.73
+18.3
YoY
|
-254.4%
-9.8
YoY
|
|
|
SOPH
SOPHiA GENETICS SA
|
462.26M
|
Composite
40.2
Moat
31.5
|
23.50
+1.9
YoY
|
-91.8%
-90.7
YoY
|
|
457.52M
|
Composite
50.6
Moat
47.1
|
11.93
-9.4
YoY
|
-
No YoY
|
|
|
457.21M
|
Composite
46.5
Moat
30.4
|
16.89
-23.5
YoY
|
-268.1%
-176.5
YoY
|
|
|
453.92M
|
Composite
51.5
Moat
54.0
|
-
No YoY
|
7.8%
+3.9
YoY
|
|
|
449.80M
|
Composite
57.1
Moat
47.0
|
12.73
-21.5
YoY
|
-3.6%
+20.3
YoY
|
|
|
442.90M
|
Composite
61.8
Moat
67.0
|
72.45
+46.1
YoY
|
-16.8%
-15.2
YoY
|
|
|
431.10M
|
Composite
62.1
Moat
30.1
|
14.51
-16.6
YoY
|
-
No YoY
|
|
|
428.06M
|
Composite
36.6
Moat
38.9
|
0.15
No YoY
|
-0.4%
-2.1
YoY
|
|
|
427.20M
|
Composite
42.6
Moat
36.6
|
2.89
-11.2
YoY
|
-7.1%
+11.8
YoY
|
|
|
425.02M
|
Composite
50.0
Moat
45.2
|
30.75
-64.7
YoY
|
-56.2%
-23.4
YoY
|
|
|
PRTC
PureTech Health plc
|
423.21M
|
Composite
43.9
Moat
43.7
|
39.09
+6.3
YoY
|
-21.1%
+10.4
YoY
|
|
422.10M
|
Composite
50.4
Moat
59.1
|
6.50
-219.6
YoY
|
15.9%
+24.0
YoY
|
|
|
KMDA
Kamada Ltd.
|
417.84M
|
Composite
53.6
Moat
65.8
|
25.29
No YoY
|
14.5%
+2.1
YoY
|
|
416.62M
|
Composite
54.3
Moat
65.7
|
13.53
-7.1
YoY
|
-9.6%
+10.7
YoY
|
|
|
416.00M
|
Composite
51.9
Moat
44.5
|
51.01
+17.1
YoY
|
-66.6%
No YoY
|
|
|
415.44M
|
Composite
56.0
Moat
54.4
|
24.73
+0.7
YoY
|
-
No YoY
|
|
|
414.97M
|
Composite
67.6
Moat
41.0
|
42.26
+24.8
YoY
|
-23.8%
-12.6
YoY
|
|
|
414.37M
|
Composite
61.4
Moat
63.2
|
117.6
+79.8
YoY
|
-1.3%
+0.5
YoY
|
|
|
411.21M
|
Composite
43.2
Moat
33.9
|
68.59
+59.1
YoY
|
-25.7%
-1.0
YoY
|
|
|
405.81M
|
Composite
57.1
Moat
46.2
|
30.09
+9.2
YoY
|
-15.4%
-1.6
YoY
|
|
|
404.79M
|
Composite
42.2
Moat
39.5
|
176.3
+134.0
YoY
|
-0.9%
+0.5
YoY
|
|
|
402.11M
|
Composite
66.6
Moat
74.5
|
61.47
No YoY
|
16.3%
+2.9
YoY
|
|
|
396.53M
|
Composite
48.2
Moat
32.7
|
22.13
+4.2
YoY
|
-92.5%
-62.0
YoY
|
|
|
TBRG
TruBridge, Inc.
|
393.60M
|
Composite
58.9
Moat
56.8
|
-
No YoY
|
6.0%
+4.2
YoY
|
|
392.93M
|
Composite
59.8
Moat
56.6
|
27.43
-12.8
YoY
|
39.4%
No YoY
|
|
|
383.70M
|
Composite
59.6
Moat
68.3
|
28.93
-256.4
YoY
|
-70.0%
-49.5
YoY
|
|
|
383.61M
|
Composite
51.0
Moat
63.5
|
15.31
-6.7
YoY
|
10.0%
+41.4
YoY
|
|
|
AUNA
Auna SA
|
382.65M
|
Composite
48.4
Moat
63.1
|
-
No YoY
|
14.4%
-2.6
YoY
|
|
ELMD
Electromed, Inc.
|
379.40M
|
Composite
72.7
Moat
82.7
|
142.6
No YoY
|
15.1%
+3.1
YoY
|
|
373.51M
|
Composite
52.0
Moat
53.2
|
35.46
+26.1
YoY
|
-2.5%
+52.8
YoY
|
|
|
370.77M
|
Composite
58.6
Moat
64.9
|
-
No YoY
|
8.2%
-0.6
YoY
|
|
|
366.20M
|
Composite
50.8
Moat
31.1
|
30.28
+5.8
YoY
|
-1.1%
+94.5
YoY
|
|
|
362.50M
|
Composite
54.1
Moat
46.7
|
23.04
-4.2
YoY
|
-22.2%
-7.9
YoY
|
|
|
361.53M
|
Composite
43.2
Moat
23.9
|
21.06
-127.8
YoY
|
-2.1%
0.0
YoY
|
|
|
PALI
Palisade Bio, Inc.
|
361.05M
|
Composite
53.2
Moat
42.6
|
147.6
+137.9
YoY
|
-51.4%
No YoY
|
|
358.14M
|
Composite
66.9
Moat
61.3
|
35.39
+26.1
YoY
|
-14.2%
-19.4
YoY
|
|
|
354.91M
|
Composite
51.8
Moat
26.1
|
19.77
-7.6
YoY
|
-5600.8%
-1989.8
YoY
|
|
|
352.87M
|
Composite
51.9
Moat
61.6
|
22.15
-7.0
YoY
|
-2.7%
+1.8
YoY
|
|
|
347.66M
|
Composite
49.6
Moat
59.6
|
77.20
+16.1
YoY
|
-
No YoY
|
|
|
346.78M
|
Composite
60.0
Moat
32.1
|
45.74
+37.9
YoY
|
-163.3%
-147.0
YoY
|
|
|
334.58M
|
Composite
56.9
Moat
59.5
|
23.56
-2.5
YoY
|
-2.8%
No YoY
|
|
|
331.91M
|
Composite
42.8
Moat
50.2
|
15.35
+1.1
YoY
|
-2.7%
+0.4
YoY
|
|
|
OABI
OmniAb, Inc.
|
324.74M
|
Composite
61.2
Moat
60.2
|
17.78
-0.2
YoY
|
-3.7%
-0.9
YoY
|
|
321.59M
|
Composite
52.9
Moat
59.9
|
35.38
+10.5
YoY
|
-1.5%
+0.8
YoY
|
|
|
319.26M
|
Composite
47.9
Moat
39.6
|
25.67
-9.9
YoY
|
-
No YoY
|
|
|
317.05M
|
Composite
29.9
Moat
44.5
|
113.8
+93.2
YoY
|
-6.5%
+33.6
YoY
|
|
|
316.54M
|
Composite
51.7
Moat
63.6
|
109.0
No YoY
|
9.9%
+5.5
YoY
|
|
|
MASS
908 Devices Inc.
|
307.42M
|
Composite
47.4
Moat
49.4
|
57.23
+29.9
YoY
|
-45.7%
+17.0
YoY
|
|
305.72M
|
Composite
55.6
Moat
28.4
|
10.61
-9.6
YoY
|
-
No YoY
|
|
|
305.46M
|
Composite
45.7
Moat
36.6
|
-
No YoY
|
-3.2%
-2.3
YoY
|
|
|
302.80M
|
Composite
53.0
Moat
75.8
|
25.89
+18.6
YoY
|
-
No YoY
|
|
|
IFRX
InflaRx N.V.
|
302.69M
|
Composite
45.0
Moat
14.6
|
15.79
+2.7
YoY
|
-1645.3%
-1326.1
YoY
|
|
302.31M
|
Composite
51.0
Moat
54.3
|
36.34
+11.9
YoY
|
-25.5%
+1.1
YoY
|
|
|
295.28M
|
Composite
41.2
Moat
48.1
|
20.31
-87.5
YoY
|
-31.0%
+62.3
YoY
|
|
|
295.00M
|
Composite
35.6
Moat
38.2
|
48.78
+20.6
YoY
|
-59.2%
-46.4
YoY
|
|
|
294.96M
|
Composite
49.8
Moat
46.9
|
0.81
+0.4
YoY
|
-43.5%
+4.6
YoY
|
|
|
291.81M
|
Composite
47.6
Moat
52.4
|
30.19
-33.9
YoY
|
-3.4%
+2.5
YoY
|
|
|
SGHT
Sight Sciences, Inc.
|
291.09M
|
Composite
50.3
Moat
54.4
|
37.17
-27.5
YoY
|
-47.9%
+15.3
YoY
|
|
TKNO
Alpha Teknova, Inc.
|
290.59M
|
Composite
43.2
Moat
33.3
|
29.62
+0.2
YoY
|
-41.9%
+27.4
YoY
|
|
MGNX
MacroGenics, Inc.
|
290.50M
|
Composite
51.5
Moat
62.2
|
28.12
-7.3
YoY
|
-48.7%
+25.0
YoY
|
|
287.79M
|
Composite
39.2
Moat
50.1
|
8.91
+4.6
YoY
|
-
No YoY
|
|
|
287.25M
|
Composite
49.8
Moat
16.3
|
7.48
+0.7
YoY
|
-
No YoY
|
|
|
279.29M
|
Composite
41.0
Moat
33.7
|
19.08
+4.3
YoY
|
-1.9%
+1.4
YoY
|
|
|
279.02M
|
Composite
36.7
Moat
50.0
|
34.82
+8.7
YoY
|
-41.3%
-38.9
YoY
|
|
|
277.44M
|
Composite
47.3
Moat
23.3
|
6.89
+1.3
YoY
|
-
No YoY
|
|
|
277.20M
|
Composite
55.1
Moat
34.0
|
6.39
-6.2
YoY
|
-
No YoY
|
|
|
SRZN
Surrozen, Inc.
|
272.84M
|
Composite
44.4
Moat
55.6
|
35.41
+11.9
YoY
|
-12.1%
-9.7
YoY
|
|
268.80M
|
Composite
48.1
Moat
48.4
|
18.76
-9.3
YoY
|
-2.6%
+0.5
YoY
|
|
|
266.65M
|
Composite
43.4
Moat
56.1
|
27.61
-93.7
YoY
|
-6.2%
-28.5
YoY
|
|
|
ACIU
AC Immune SA
|
256.40M
|
Composite
47.0
Moat
30.5
|
15.84
-4.6
YoY
|
-19.3%
-17.4
YoY
|
|
ADAG
Adagene Inc.
|
254.38M
|
Composite
53.8
Moat
38.8
|
57.12
+22.7
YoY
|
-2.8%
+345.6
YoY
|
|
251.43M
|
Composite
52.9
Moat
40.7
|
14.91
-59.1
YoY
|
-4.3%
+3.3
YoY
|
|
|
251.00M
|
Composite
46.7
Moat
73.2
|
-
No YoY
|
25.1%
-25.4
YoY
|
|
|
250.21M
|
Composite
65.8
Moat
57.4
|
31.53
-20.0
YoY
|
-
No YoY
|
|
|
249.60M
|
Composite
60.3
Moat
67.0
|
20.67
-5.0
YoY
|
-38.9%
-37.8
YoY
|
|
|
243.79M
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
NKTX
Nkarta, Inc.
|
241.82M
|
Composite
59.1
Moat
71.8
|
37.38
+5.2
YoY
|
-
No YoY
|
|
241.45M
|
Composite
57.5
Moat
65.3
|
24.48
-1.9
YoY
|
-
No YoY
|
|
|
239.21M
|
Composite
61.3
Moat
58.0
|
70.38
-1233.6
YoY
|
-24.8%
+14.7
YoY
|
|
|
IVVD
Invivyd, Inc.
|
236.78M
|
Composite
63.8
Moat
64.2
|
46.79
+41.9
YoY
|
-1.0%
+5.9
YoY
|
|
236.35M
|
Composite
54.5
Moat
63.1
|
21.07
+3.3
YoY
|
-1.5%
+36.6
YoY
|
|
|
CLLS
Cellectis S.A.
|
233.80M
|
Composite
55.8
Moat
56.7
|
63.55
-35.3
YoY
|
-45.3%
-43.9
YoY
|
|
CGEN
Compugen Ltd.
|
233.62M
|
Composite
65.1
Moat
73.9
|
16.95
-12.4
YoY
|
43.0%
+96.5
YoY
|
|
CDXS
Codexis, Inc.
|
232.70M
|
Composite
59.7
Moat
64.9
|
48.44
+30.6
YoY
|
-54.5%
+43.9
YoY
|
|
232.34M
|
Composite
47.5
Moat
47.9
|
26.10
+10.2
YoY
|
-1.5%
+22.8
YoY
|
|
|
231.16M
|
Composite
52.1
Moat
69.7
|
10.15
-0.1
YoY
|
-62.1%
+20.1
YoY
|
|
|
231.00M
|
Composite
54.8
Moat
66.2
|
33.12
-24.0
YoY
|
-
No YoY
|
|
|
BDSX
Biodesix, Inc.
|
229.38M
|
Composite
41.3
Moat
54.0
|
9.79
+3.3
YoY
|
-31.4%
+16.7
YoY
|
|
LFMD
LifeMD, Inc.
|
228.75M
|
Composite
42.0
Moat
42.2
|
2.07
-12.9
YoY
|
-4.0%
+9.2
YoY
|
|
226.01M
|
Composite
52.9
Moat
65.3
|
13.62
+11.1
YoY
|
-59.7%
-58.5
YoY
|
|
|
225.36M
|
Composite
54.4
Moat
40.9
|
44.47
+27.6
YoY
|
-14.9%
+66.5
YoY
|
|
|
225.23M
|
Composite
53.5
Moat
68.3
|
41.77
+9.9
YoY
|
27.7%
+86.7
YoY
|
|
|
222.35M
|
Composite
52.3
Moat
56.9
|
17.80
-191.2
YoY
|
-3.3%
-2.2
YoY
|
|
|
SMTI
Sanara MedTech Inc.
|
222.04M
|
Composite
50.4
Moat
60.9
|
8011.2
+7992.2
YoY
|
8.9%
+7.4
YoY
|
|
220.83M
|
Composite
61.3
Moat
54.1
|
78.78
-720.1
YoY
|
-4.1%
-2.9
YoY
|
|
|
219.43M
|
Composite
43.2
Moat
79.4
|
73.10
+60.0
YoY
|
-
No YoY
|
|
|
SPOK
Spok Holdings, Inc.
|
218.48M
|
Composite
58.0
Moat
73.8
|
-
No YoY
|
14.4%
-0.1
YoY
|
|
217.72M
|
Composite
60.8
Moat
69.2
|
-
No YoY
|
29.6%
-3.6
YoY
|
|
|
214.09M
|
Composite
49.8
Moat
51.6
|
461.3
No YoY
|
-9.8%
-5.6
YoY
|
|
|
QTTB
Q32 Bio Inc.
|
213.48M
|
Composite
57.9
Moat
79.6
|
17.28
+3.5
YoY
|
31.4%
+24.2
YoY
|
|
RXST
RxSight, Inc.
|
210.29M
|
Composite
46.1
Moat
50.3
|
176.5
+8.5
YoY
|
-35.8%
-9.5
YoY
|
|
209.57M
|
Composite
43.7
Moat
47.3
|
20.64
-8.0
YoY
|
-40.0%
-4.5
YoY
|
|
|
KRRO
Korro Bio, Inc.
|
206.24M
|
Composite
51.2
Moat
40.1
|
11.48
-13.7
YoY
|
-13.7%
+26.8
YoY
|
|
203.72M
|
Composite
55.2
Moat
45.1
|
24.96
+5.5
YoY
|
-9.4%
-1.9
YoY
|
|
|
203.51M
|
Composite
41.5
Moat
63.9
|
37.31
-10.3
YoY
|
-1.1%
+68.0
YoY
|
|
|
203.50M
|
Composite
49.7
Moat
56.3
|
359.6
+331.4
YoY
|
-7.2%
+11.9
YoY
|
|
|
203.05M
|
Composite
41.7
Moat
32.2
|
1.87
-0.7
YoY
|
-47.4%
No YoY
|
|
|
IMUX
Immunic, Inc.
|
201.33M
|
Composite
57.9
Moat
35.1
|
2.17
-2.9
YoY
|
-
No YoY
|
|
THAR
Tharimmune, Inc.
|
198.86M
|
Composite
51.2
Moat
12.1
|
3.92
-14.1
YoY
|
-
No YoY
|
|
PDEX
Pro-Dex, Inc.
|
198.08M
|
Composite
57.9
Moat
60.7
|
51.07
+28.3
YoY
|
16.1%
+2.7
YoY
|
|
196.60M
|
Composite
56.1
Moat
67.8
|
-
No YoY
|
8.3%
+3.2
YoY
|
|
|
HITI
High Tide Inc.
|
195.37M
|
Composite
54.9
Moat
44.9
|
-
No YoY
|
2.6%
-0.3
YoY
|
|
195.01M
|
Composite
47.3
Moat
41.5
|
12.14
-11.7
YoY
|
-
No YoY
|
|
|
EDAP
EDAP TMS S.A.
|
194.90M
|
Composite
35.0
Moat
26.9
|
14.96
-9.4
YoY
|
-35.0%
-3.0
YoY
|
|
192.74M
|
Composite
56.5
Moat
40.9
|
23.24
-3.5
YoY
|
-13.2%
+19.3
YoY
|
|
|
192.41M
|
Composite
55.1
Moat
43.1
|
15.06
-3.1
YoY
|
-12.2%
+4.5
YoY
|
|
|
191.00M
|
Composite
76.1
Moat
67.4
|
30.29
-375.4
YoY
|
-10.4%
-17.8
YoY
|
|
|
MDWD
MediWound Ltd.
|
189.06M
|
Composite
53.4
Moat
52.6
|
39.56
+1.5
YoY
|
-1.5%
+94.4
YoY
|
|
188.90M
|
Composite
36.8
Moat
25.4
|
8.96
+2.9
YoY
|
-10.5%
+0.0
YoY
|
|
|
HUMA
Humacyte, Inc.
|
188.83M
|
Composite
47.4
Moat
32.0
|
5.77
+0.3
YoY
|
-53.1%
No YoY
|
|
EMBC
Embecta Corp.
|
188.66M
|
Composite
48.3
Moat
69.5
|
-
No YoY
|
27.4%
+2.0
YoY
|
|
187.48M
|
Composite
48.8
Moat
36.2
|
18.37
-80.3
YoY
|
-79.2%
-40.4
YoY
|
|
|
187.15M
|
Composite
59.8
Moat
69.2
|
15.97
+1.7
YoY
|
-20.1%
+20.1
YoY
|
|
|
186.80M
|
Composite
54.1
Moat
45.9
|
47.60
+26.5
YoY
|
-12.2%
+27.0
YoY
|
|
|
ACOG
Alpha Cognition Inc.
|
185.52M
|
Composite
56.2
Moat
51.2
|
38.89
-36.2
YoY
|
-2.2%
No YoY
|
|
184.99M
|
Composite
52.3
Moat
55.3
|
50.72
+8.5
YoY
|
-4.8%
+65.1
YoY
|
|
|
184.45M
|
Composite
49.9
Moat
36.5
|
17.68
+9.5
YoY
|
-
No YoY
|
|
|
ALEC
Alector, Inc.
|
181.53M
|
Composite
45.7
Moat
47.6
|
16.69
-4.9
YoY
|
-7.4%
-6.0
YoY
|
|
180.16M
|
Composite
56.7
Moat
24.8
|
13.67
-12.3
YoY
|
-
No YoY
|
|
|
179.00M
|
Composite
60.0
Moat
36.9
|
30.38
-12.4
YoY
|
-63.5%
No YoY
|
|
|
178.80M
|
Composite
56.7
Moat
58.6
|
21.01
-28.3
YoY
|
-2.7%
-1.1
YoY
|
|
|
178.23M
|
Composite
51.2
Moat
41.9
|
25.93
-3.1
YoY
|
-40.2%
+20.9
YoY
|
|
|
177.31M
|
Composite
37.3
Moat
47.3
|
4.05
+1.1
YoY
|
-
No YoY
|
|
|
INGN
Inogen, Inc
|
176.80M
|
Composite
48.8
Moat
48.5
|
127.9
-348.8
YoY
|
-8.7%
+4.0
YoY
|
|
STXS
Stereotaxis, Inc.
|
175.93M
|
Composite
36.8
Moat
33.6
|
11.77
-5.5
YoY
|
-68.3%
+23.6
YoY
|
|
NYXH
Nyxoah SA
|
171.57M
|
Composite
37.5
Moat
44.1
|
8.35
-12.5
YoY
|
-8.3%
+4.7
YoY
|
|
171.42M
|
Composite
44.6
Moat
37.2
|
481.5
+468.3
YoY
|
-9.3%
-3.7
YoY
|
|
|
OWLT
Owlet, Inc.
|
171.40M
|
Composite
51.9
Moat
44.3
|
39.43
+17.8
YoY
|
-7.8%
+18.1
YoY
|
|
171.07M
|
Composite
59.2
Moat
51.9
|
165.2
-37.3
YoY
|
-7.5%
+4.2
YoY
|
|
|
IPHA
Innate Pharma S.A.
|
170.75M
|
Composite
40.7
Moat
41.8
|
12.65
-127.9
YoY
|
-19.2%
-15.1
YoY
|
|
167.48M
|
Composite
49.9
Moat
25.3
|
10.39
-37.2
YoY
|
-907.4%
-821.2
YoY
|
|
|
PYXS
Pyxis Oncology, Inc.
|
167.26M
|
Composite
48.8
Moat
44.3
|
12.63
-13.8
YoY
|
-6.1%
-1.8
YoY
|
|
166.75M
|
Composite
54.3
Moat
50.6
|
23.33
+3.0
YoY
|
-
No YoY
|
|
|
HCAT
Health Catalyst, Inc
|
165.52M
|
Composite
37.5
Moat
38.8
|
115.3
-8.4
YoY
|
-13.7%
+5.1
YoY
|
|
ADCT
ADC Therapeutics SA
|
165.35M
|
Composite
50.3
Moat
64.0
|
22.21
-2.1
YoY
|
-1.3%
+0.5
YoY
|
|
164.62M
|
Composite
43.1
Moat
34.0
|
99.25
-456.3
YoY
|
-17.5%
-11.7
YoY
|
|
|
161.90M
|
Composite
64.8
Moat
62.4
|
-
No YoY
|
-0.8%
-2.2
YoY
|
|
|
161.63M
|
Composite
40.0
Moat
10.4
|
3.75
-25.5
YoY
|
-
No YoY
|
|
|
PEPG
PepGen Inc.
|
159.09M
|
Composite
55.8
Moat
56.0
|
21.82
+4.3
YoY
|
-
No YoY
|
|
158.00M
|
Composite
43.4
Moat
41.5
|
103.8
+79.3
YoY
|
-14.5%
-18.2
YoY
|
|
|
152.38M
|
Composite
42.2
Moat
35.5
|
33.17
+11.7
YoY
|
-42.2%
+43.3
YoY
|
|
|
151.90M
|
Composite
49.6
Moat
36.0
|
27.00
No YoY
|
-14.5%
+0.5
YoY
|
|
|
149.26M
|
Composite
49.6
Moat
35.5
|
21.79
-8.5
YoY
|
-12.3%
-3.6
YoY
|
|
|
149.02M
|
Composite
53.8
Moat
37.1
|
10.31
+6.6
YoY
|
-
No YoY
|
|
|
148.32M
|
Composite
49.6
Moat
30.6
|
3.93
+1.9
YoY
|
-338.5%
-326.2
YoY
|
|
|
145.40M
|
Composite
57.8
Moat
45.4
|
19.62
+4.8
YoY
|
-1.8%
+2.8
YoY
|
|
|
CBUS
Cibus, Inc.
|
145.00M
|
Composite
58.4
Moat
43.0
|
2.35
-0.6
YoY
|
-18.5%
-0.5
YoY
|
|
142.00M
|
Composite
49.6
Moat
42.4
|
6.63
+5.0
YoY
|
-13.2%
No YoY
|
|
|
140.44M
|
Composite
47.0
Moat
32.8
|
15.81
+4.8
YoY
|
-30.8%
-11.8
YoY
|
|
|
138.74M
|
Composite
53.4
Moat
51.4
|
25.21
-2.9
YoY
|
-
No YoY
|
|
|
CVRX
CVRx, Inc.
|
137.99M
|
Composite
48.6
Moat
46.3
|
22.62
-9.9
YoY
|
-90.5%
-89.3
YoY
|
|
MXCT
MaxCyte, Inc.
|
137.12M
|
Composite
50.5
Moat
41.8
|
35.94
-31.2
YoY
|
-1.4%
-0.0
YoY
|
|
137.06M
|
Composite
49.7
Moat
37.4
|
17.61
+9.3
YoY
|
-11.4%
-6.3
YoY
|
|
|
RCEL
Avita Medical, Inc.
|
135.73M
|
Composite
43.3
Moat
56.4
|
7.00
-1.8
YoY
|
-59.4%
+28.7
YoY
|
|
135.10M
|
Composite
53.7
Moat
59.3
|
15.02
+7.6
YoY
|
-96.6%
-92.1
YoY
|
|
|
AGEN
Agenus Inc.
|
134.92M
|
Composite
50.9
Moat
62.8
|
0.47
-2.6
YoY
|
-18.0%
-16.8
YoY
|
|
VANI
Vivani Medical, Inc.
|
134.53M
|
Composite
53.8
Moat
46.9
|
8.01
-2.6
YoY
|
-
No YoY
|
|
132.78M
|
Composite
64.0
Moat
73.8
|
13.87
+7.1
YoY
|
7.6%
+9.9
YoY
|
|
|
132.60M
|
Composite
42.2
Moat
42.3
|
45.88
+13.2
YoY
|
-5.9%
+15.8
YoY
|
|
|
GNLX
Genelux Corporation
|
132.34M
|
Composite
48.7
Moat
14.8
|
6.93
-10.5
YoY
|
-4151.8%
-189.8
YoY
|
|
BGM
BGM Group Ltd.
|
131.66M
|
Composite
52.1
Moat
47.9
|
-
No YoY
|
-1.4%
+3.8
YoY
|
|
ENGN
enGene Holdings Inc.
|
128.62M
|
Composite
56.9
Moat
41.9
|
23.43
-35.8
YoY
|
-
No YoY
|
|
127.97M
|
Composite
51.9
Moat
50.8
|
2.62
-3.3
YoY
|
-
No YoY
|
|
|
JYNT
The Joint Corp.
|
127.30M
|
Composite
46.0
Moat
48.8
|
-
No YoY
|
-1.7%
+1.8
YoY
|
|
GUTS
Fractyl Health, Inc.
|
125.57M
|
Composite
46.9
Moat
23.7
|
12.36
+3.1
YoY
|
-1005.7%
0.0
YoY
|
|
FONR
Fonar Corporation
|
125.10M
|
Composite
57.8
Moat
59.7
|
-
No YoY
|
11.1%
-5.0
YoY
|
|
124.93M
|
Composite
42.4
Moat
40.8
|
72.29
+64.9
YoY
|
-
No YoY
|
|
|
123.38M
|
Composite
52.5
Moat
51.3
|
52.32
+7.6
YoY
|
-2.8%
+2.0
YoY
|
|
|
122.75M
|
Composite
60.1
Moat
66.6
|
38.27
+11.2
YoY
|
12.0%
+14.7
YoY
|
|
|
SEER
Seer, Inc.
|
120.96M
|
Composite
57.0
Moat
55.6
|
50.19
-11.3
YoY
|
-4.8%
+2.3
YoY
|
|
118.92M
|
Composite
50.1
Moat
61.5
|
6.63
-15.0
YoY
|
-
No YoY
|
|
|
117.84M
|
Composite
55.0
Moat
67.5
|
22.96
No YoY
|
11.0%
+17.8
YoY
|
|
|
117.04M
|
Composite
42.4
Moat
32.6
|
10.77
-3.9
YoY
|
-490.9%
No YoY
|
|
|
STIM
Neuronetics, Inc.
|
115.50M
|
Composite
41.3
Moat
45.5
|
16.70
+9.5
YoY
|
-21.1%
+25.1
YoY
|
|
114.24M
|
Composite
68.5
Moat
58.9
|
23.98
+2.9
YoY
|
-1.7%
+0.5
YoY
|
|
|
112.18M
|
Composite
59.0
Moat
56.9
|
20.52
+11.4
YoY
|
-33.6%
-24.9
YoY
|
|
|
HYPR
Hyperfine, Inc.
|
111.68M
|
Composite
43.4
Moat
36.6
|
15.06
+3.4
YoY
|
-2.7%
+0.6
YoY
|
|
XGN
Exagen Inc.
|
111.62M
|
Composite
42.8
Moat
46.0
|
28.38
+8.5
YoY
|
-21.1%
+3.4
YoY
|
|
109.80M
|
Composite
46.7
Moat
36.4
|
3.10
-6.5
YoY
|
-
No YoY
|
|
|
109.60M
|
Composite
50.5
Moat
36.2
|
25.39
-7.2
YoY
|
-52.4%
-26.8
YoY
|
|
|
109.30M
|
Composite
66.6
Moat
63.3
|
14.48
+5.9
YoY
|
-1.1%
+0.8
YoY
|
|
|
109.08M
|
Composite
57.3
Moat
66.4
|
24.37
-24.5
YoY
|
-4.9%
-2.4
YoY
|
|
|
107.73M
|
Composite
61.5
Moat
84.5
|
18.99
-4.6
YoY
|
28.4%
No YoY
|
|
|
106.85M
|
Composite
38.2
Moat
48.9
|
5.29
+4.1
YoY
|
-3.5%
+23.2
YoY
|
|
|
PYPD
PolyPid Ltd.
|
103.92M
|
Composite
54.4
Moat
21.8
|
5.57
-3.0
YoY
|
-
No YoY
|
|
ICCC
ImmuCell Corporation
|
103.63M
|
Composite
68.5
Moat
72.1
|
2.51
-42.5
YoY
|
6.0%
+12.2
YoY
|
|
97.90M
|
Composite
41.2
Moat
12.1
|
7.92
-2.9
YoY
|
-1328.7%
-812.5
YoY
|
|
|
97.55M
|
Composite
52.8
Moat
29.0
|
17.96
+7.4
YoY
|
-
No YoY
|
|
|
97.50M
|
Composite
57.1
Moat
54.0
|
42.61
+30.6
YoY
|
-3.5%
No YoY
|
|
|
CCLD
CareCloud, Inc.
|
96.90M
|
Composite
61.0
Moat
68.4
|
-
No YoY
|
9.5%
+0.8
YoY
|
|
95.39M
|
Composite
40.2
Moat
57.0
|
201.8
+134.2
YoY
|
-10.2%
+52.3
YoY
|
|
|
ACET
Adicet Bio, Inc.
|
93.88M
|
Composite
51.5
Moat
54.1
|
19.97
-2.9
YoY
|
-2.9%
+3.4
YoY
|
|
BMEA
Biomea Fusion, Inc.
|
93.27M
|
Composite
55.0
Moat
34.9
|
9.52
+3.7
YoY
|
-
No YoY
|
|
92.83M
|
Composite
45.3
Moat
60.4
|
1.99
-4.9
YoY
|
-
No YoY
|
|
|
90.61M
|
Composite
32.5
Moat
41.4
|
2.24
-2.1
YoY
|
-2.0%
-0.4
YoY
|
|
|
90.50M
|
Composite
53.4
Moat
53.0
|
352.1
No YoY
|
-6.3%
+10.7
YoY
|
|
|
90.25M
|
Composite
47.1
Moat
35.9
|
18.45
-10.8
YoY
|
-82.6%
-11.3
YoY
|
|
|
89.61M
|
Composite
47.4
Moat
60.9
|
2.00
-5.4
YoY
|
29.7%
+94.4
YoY
|
|
|
89.30M
|
Composite
55.2
Moat
38.5
|
19.96
+16.0
YoY
|
-
No YoY
|
|
|
NRXS
Neuraxis, Inc.
|
89.29M
|
Composite
60.7
Moat
47.8
|
9.26
+2.0
YoY
|
-2.2%
+0.5
YoY
|
|
88.77M
|
Composite
55.0
Moat
9.5
|
5.51
-1.8
YoY
|
-
No YoY
|
|
|
OKYO
OKYO Pharma Limited
|
88.17M
|
Composite
43.5
Moat
60.0
|
10.34
+9.3
YoY
|
-
No YoY
|
|
87.74M
|
Composite
56.1
Moat
57.6
|
22.35
-10.4
YoY
|
-
No YoY
|
|
|
87.34M
|
Composite
57.8
Moat
27.4
|
3.00
+3.0
YoY
|
-
No YoY
|
|
|
85.70M
|
Composite
34.7
Moat
48.0
|
-
No YoY
|
-8.5%
-4.7
YoY
|
|
|
GOSS
Gossamer Bio, Inc.
|
85.55M
|
Composite
50.5
Moat
57.0
|
9.59
-1009.5
YoY
|
-3.4%
+48.9
YoY
|
|
84.51M
|
Composite
37.8
Moat
33.9
|
14.79
+1.0
YoY
|
-1.4%
+0.4
YoY
|
|
|
RLYB
Rallybio Corporation
|
83.87M
|
Composite
51.3
Moat
48.0
|
22.03
+6.1
YoY
|
-38.5%
+56.6
YoY
|
|
ENTX
Entera Bio Ltd.
|
83.70M
|
Composite
47.6
Moat
29.9
|
11.57
-3.7
YoY
|
-274.5%
-221.5
YoY
|
|
ANVS
Annovis Bio, Inc.
|
82.96M
|
Composite
52.4
Moat
30.8
|
9.15
+3.4
YoY
|
-
No YoY
|
|
82.49M
|
Composite
44.5
Moat
39.8
|
43.76
+27.4
YoY
|
-55.8%
+43.9
YoY
|
|
|
82.34M
|
Composite
49.3
Moat
45.2
|
13.52
-17.9
YoY
|
-13.2%
+34.7
YoY
|
|
|
82.00M
|
Composite
41.2
Moat
34.3
|
92.60
+17.5
YoY
|
-1.5%
-0.2
YoY
|
|
|
NNOX
NANO-X IMAGING LTD
|
81.43M
|
Composite
44.6
Moat
36.9
|
17.54
-6.5
YoY
|
-4.7%
+0.4
YoY
|
|
81.11M
|
Composite
55.5
Moat
71.4
|
20.28
-11.3
YoY
|
-1.6%
+6.3
YoY
|
|
|
80.68M
|
Composite
57.3
Moat
73.3
|
5.12
No YoY
|
8.5%
+22.3
YoY
|
|
|
80.28M
|
Composite
41.1
Moat
14.4
|
18.36
-20.7
YoY
|
-450.7%
+25.1
YoY
|
|
|
77.63M
|
Composite
48.3
Moat
29.2
|
13.54
+6.9
YoY
|
-403.3%
-276.4
YoY
|
|
|
76.61M
|
Composite
44.7
Moat
65.7
|
0.23
-8.9
YoY
|
-
No YoY
|
|
|
76.43M
|
Composite
29.6
Moat
33.5
|
3.29
-0.9
YoY
|
-18.5%
+2.3
YoY
|
|
|
IBIO
iBio, Inc.
|
75.01M
|
Composite
49.4
Moat
36.7
|
6.73
-2.5
YoY
|
-46.5%
+27.4
YoY
|
|
72.19M
|
Composite
49.2
Moat
58.5
|
2.59
-4.9
YoY
|
-2.7%
-1.0
YoY
|
|
|
71.98M
|
Composite
66.1
Moat
63.3
|
14.48
+5.9
YoY
|
-1.1%
+0.8
YoY
|
|
|
LNSR
LENSAR, Inc.
|
71.78M
|
Composite
53.3
Moat
44.2
|
14.55
-103.9
YoY
|
-42.1%
-29.1
YoY
|
|
TLPH
Talphera, Inc.
|
70.58M
|
Composite
39.2
Moat
12.6
|
21.52
+13.1
YoY
|
-481.6%
-455.6
YoY
|
|
XBIT
XBiotech Inc.
|
69.82M
|
Composite
50.9
Moat
48.5
|
37.74
-29.2
YoY
|
-8.6%
-7.2
YoY
|
|
69.60M
|
Composite
57.4
Moat
57.2
|
13.20
-4.5
YoY
|
-
No YoY
|
|
|
69.45M
|
Composite
53.2
Moat
41.0
|
8.86
+7.9
YoY
|
-9.6%
+177.7
YoY
|
|
|
69.44M
|
Composite
49.7
Moat
39.6
|
17.85
-9.6
YoY
|
-116.5%
-103.4
YoY
|
|
|
69.24M
|
Composite
54.8
Moat
42.2
|
31.88
+22.5
YoY
|
-23.5%
+24.8
YoY
|
|
|
MNOV
MediciNova, Inc.
|
68.91M
|
Composite
52.9
Moat
40.6
|
37.68
-7.8
YoY
|
-32.4%
-22.5
YoY
|
|
BTMD
Biote Corp.
|
68.55M
|
Composite
47.2
Moat
66.9
|
103.8
No YoY
|
18.5%
+2.5
YoY
|
|
68.33M
|
Composite
33.3
Moat
11.1
|
3.84
-3.6
YoY
|
-47.1%
No YoY
|
|
|
FORA
Forian Inc.
|
67.60M
|
Composite
46.3
Moat
40.0
|
28.24
+6.6
YoY
|
-8.2%
+19.4
YoY
|
|
67.07M
|
Composite
35.7
Moat
29.1
|
8.58
No YoY
|
-
No YoY
|
|
|
CING
Cingulate Inc.
|
66.67M
|
Composite
57.0
Moat
14.5
|
7.62
-0.3
YoY
|
-
No YoY
|
|
66.56M
|
Composite
44.2
Moat
42.8
|
6.03
+0.3
YoY
|
-
No YoY
|
|
|
66.13M
|
Composite
57.3
Moat
55.0
|
18.42
-21.2
YoY
|
-
No YoY
|
|
|
66.03M
|
Composite
55.0
Moat
59.0
|
5.91
-2.9
YoY
|
-45.3%
-3.8
YoY
|
|
|
65.27M
|
Composite
51.8
Moat
33.7
|
2.49
-10.6
YoY
|
-119.1%
-74.6
YoY
|
|
|
64.70M
|
Composite
24.6
Moat
36.6
|
2.27
+1.0
YoY
|
-9.0%
-7.4
YoY
|
|
|
IMMP
Immutep Limited
|
62.90M
|
Composite
51.5
Moat
31.2
|
62.68
+21.4
YoY
|
-25.1%
+173.5
YoY
|
|
62.50M
|
Composite
56.8
Moat
70.1
|
-
No YoY
|
29.2%
+3.4
YoY
|
|
|
EDSA
Edesa Biotech, Inc.
|
62.42M
|
Composite
56.5
Moat
32.7
|
17.69
+15.1
YoY
|
-47362.7%
No YoY
|
|
BYSI
BeyondSpring, Inc.
|
61.30M
|
Composite
50.8
Moat
43.3
|
7.62
+5.5
YoY
|
-27.6%
+21.5
YoY
|
|
61.30M
|
Composite
25.7
Moat
29.5
|
1.19
-4.3
YoY
|
-1.0%
+57.3
YoY
|
|
|
EXOZ
eXoZymes, Inc.
|
60.03M
|
Composite
50.3
Moat
25.0
|
5.61
-8.1
YoY
|
-
No YoY
|
|
DCGO
DocGo Inc.
|
59.30M
|
Composite
31.2
Moat
34.9
|
11.08
-1070.6
YoY
|
-27.7%
-32.3
YoY
|
|
58.90M
|
Composite
49.8
Moat
65.5
|
6.25
-1.0
YoY
|
5.4%
+15.7
YoY
|
|
|
57.25M
|
Composite
52.4
Moat
56.3
|
1.00
-7.2
YoY
|
-50.8%
-11.6
YoY
|
|
|
ATYR
aTyr Pharma, Inc.
|
57.10M
|
Composite
45.8
Moat
28.2
|
15.23
+2.7
YoY
|
-408.6%
-119.6
YoY
|
|
57.09M
|
Composite
54.5
Moat
56.1
|
27.06
+21.3
YoY
|
-
No YoY
|
|
|
56.21M
|
Composite
54.0
Moat
21.9
|
0.26
+0.2
YoY
|
-
No YoY
|
|
|
ECOR
electroCore, Inc.
|
55.08M
|
Composite
38.0
Moat
50.6
|
17.02
-4.1
YoY
|
-41.1%
+7.2
YoY
|
|
55.04M
|
Composite
61.0
Moat
57.3
|
330.6
+294.5
YoY
|
-95.9%
-86.5
YoY
|
|
|
BOLD
Boundless Bio, Inc.
|
55.03M
|
Composite
52.7
Moat
44.8
|
27.67
-2.3
YoY
|
-
No YoY
|
|
MDAI
Spectral AI, Inc.
|
54.74M
|
Composite
40.5
Moat
46.8
|
18.62
+11.9
YoY
|
-43.8%
-21.5
YoY
|
|
INCR
Intercure Ltd.
|
54.70M
|
Composite
47.7
Moat
42.9
|
14.10
-8.6
YoY
|
2.5%
+21.3
YoY
|
|
54.62M
|
Composite
51.9
Moat
53.0
|
30.01
-47.8
YoY
|
-
No YoY
|
|
|
54.18M
|
Composite
50.5
Moat
31.5
|
6.00
+4.2
YoY
|
-29.1%
-14.8
YoY
|
|
|
53.86M
|
Composite
48.6
Moat
49.3
|
16.66
-4.7
YoY
|
-15.0%
No YoY
|
|
|
TIL
Instil Bio, Inc.
|
52.53M
|
Composite
54.9
Moat
66.3
|
24.95
+0.5
YoY
|
-
No YoY
|
|
COCH
Envoy Medical, Inc.
|
52.36M
|
Composite
40.2
Moat
24.1
|
2.47
-1.2
YoY
|
-92.4%
-6.8
YoY
|
|
51.75M
|
Composite
48.6
Moat
30.3
|
15.88
-9.6
YoY
|
-76.5%
-73.8
YoY
|
|
|
DRIO
DarioHealth Corp.
|
51.19M
|
Composite
36.7
Moat
28.4
|
12.04
+3.2
YoY
|
-1.6%
+0.5
YoY
|
|
ZTEK
Zentek Ltd.
|
50.80M
|
Composite
29.1
Moat
28.1
|
3.08
+2.9
YoY
|
-59.8%
-48.8
YoY
|
|
CRVO
CervoMed Inc.
|
50.59M
|
Composite
54.0
Moat
22.5
|
10.68
-17.6
YoY
|
-
No YoY
|
|
ATHA
Athira Pharma, Inc.
|
50.13M
|
Composite
54.2
Moat
37.1
|
6.33
-11.2
YoY
|
-
No YoY
|
|
49.02M
|
Composite
41.9
Moat
37.6
|
0.22
-1.1
YoY
|
-11.5%
-6.6
YoY
|
|
|
48.79M
|
Composite
44.4
Moat
23.5
|
0.02
-8.4
YoY
|
-133.4%
-65.4
YoY
|
|
|
48.07M
|
Composite
46.0
Moat
47.2
|
318.5
+189.0
YoY
|
-37.5%
-56.9
YoY
|
|
|
INMB
INmune Bio Inc.
|
47.59M
|
Composite
48.8
Moat
26.6
|
13.15
+5.6
YoY
|
-617.4%
+2428.0
YoY
|
|
MGX
Metagenomi, Inc.
|
47.44M
|
Composite
47.5
Moat
56.0
|
27.32
-8.3
YoY
|
-1.7%
0.0
YoY
|
|
47.42M
|
Composite
53.4
Moat
46.1
|
5.01
-15.3
YoY
|
-
No YoY
|
|
|
PRPO
Precipio, Inc.
|
47.30M
|
Composite
49.1
Moat
51.3
|
5.06
-0.3
YoY
|
-5.0%
+17.8
YoY
|
|
46.98M
|
Composite
31.2
Moat
19.1
|
11.34
+9.3
YoY
|
-65.1%
No YoY
|
|
|
SCYX
SCYNEXIS, Inc.
|
45.78M
|
Composite
47.1
Moat
37.4
|
90.93
+61.3
YoY
|
-78.0%
-68.1
YoY
|
|
VERU
Veru Inc.
|
45.10M
|
Composite
57.3
Moat
42.5
|
7.32
-6.9
YoY
|
-5.9%
-3.7
YoY
|
|
MYO
Myomo Inc.
|
44.80M
|
Composite
47.4
Moat
39.7
|
15.21
-75.5
YoY
|
-35.2%
-16.1
YoY
|
|
43.94M
|
Composite
50.8
Moat
38.8
|
11.55
-2.7
YoY
|
-
No YoY
|
|
|
ELUT
Elutia, Inc.
|
42.97M
|
Composite
43.5
Moat
28.2
|
9.73
+2.7
YoY
|
-1.5%
+98.1
YoY
|
|
LTRN
Lantern Pharma Inc.
|
42.74M
|
Composite
53.2
Moat
30.9
|
7.75
-8.4
YoY
|
-
No YoY
|
|
41.89M
|
Composite
49.2
Moat
36.6
|
11.32
+2.9
YoY
|
-40.2%
-17.7
YoY
|
|
|
APLM
Apollomics Inc.
|
41.29M
|
Composite
45.2
Moat
53.1
|
3.79
-0.3
YoY
|
-1.1%
No YoY
|
|
ONMD
OneMedNet Corp
|
41.28M
|
Composite
34.1
Moat
17.3
|
1.74
-3.5
YoY
|
-7.1%
+7.8
YoY
|
|
PETS
PetMed Express, Inc.
|
41.21M
|
Composite
24.1
Moat
31.8
|
9.05
No YoY
|
-17.5%
-14.6
YoY
|
|
40.90M
|
Composite
45.6
Moat
59.4
|
9.30
+6.2
YoY
|
-
No YoY
|
|
|
40.65M
|
Composite
43.6
Moat
45.8
|
23.22
-50.0
YoY
|
-2.1%
+0.6
YoY
|
|
|
RNXT
RenovoRx, Inc.
|
40.59M
|
Composite
58.2
Moat
33.6
|
7.68
-1.7
YoY
|
-11.1%
+244.0
YoY
|
|
40.44M
|
Composite
40.8
Moat
19.1
|
4.44
-20.3
YoY
|
-276.6%
+1274.0
YoY
|
|
|
PAVM
PAVmed Inc.
|
40.40M
|
Composite
38.9
Moat
14.6
|
3.55
+3.1
YoY
|
-301.3%
-286.5
YoY
|
|
39.71M
|
Composite
55.8
Moat
68.7
|
22.97
+5.1
YoY
|
-83.8%
No YoY
|
|
|
38.99M
|
Composite
51.0
Moat
44.0
|
15.41
-12.6
YoY
|
-5.8%
-4.1
YoY
|
|
|
38.66M
|
Composite
27.1
Moat
25.0
|
28.39
+22.3
YoY
|
-
No YoY
|
|
|
TELA
TELA Bio, Inc.
|
38.41M
|
Composite
38.4
Moat
49.0
|
21.62
+6.4
YoY
|
-42.0%
+18.1
YoY
|
|
37.90M
|
Composite
57.6
Moat
50.6
|
4.89
+3.2
YoY
|
1.1%
+0.8
YoY
|
|
|
NTRB
Nutriband Inc.
|
37.56M
|
Composite
48.8
Moat
47.3
|
10.69
-0.5
YoY
|
-4.1%
-1.0
YoY
|
|
37.51M
|
Composite
58.3
Moat
68.6
|
49.18
+24.8
YoY
|
-
No YoY
|
|
|
37.22M
|
Composite
36.4
Moat
34.6
|
1.71
+0.3
YoY
|
-35.8%
+28.5
YoY
|
|
|
SNPX
Synaptogenix, Inc.
|
36.76M
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
ABVC
ABVC Biopharma, Inc.
|
36.64M
|
Composite
53.5
Moat
45.5
|
3.00
+0.9
YoY
|
-9.2%
+35.2
YoY
|
|
NEPH
Nephros, Inc.
|
35.94M
|
Composite
49.9
Moat
64.0
|
91.71
+78.2
YoY
|
6.1%
+6.1
YoY
|
|
35.91M
|
Composite
46.9
Moat
29.9
|
-
No YoY
|
-58.7%
-67.9
YoY
|
|
|
BEAT
Heartbeam, Inc.
|
35.52M
|
Composite
26.0
Moat
8.9
|
3.76
+1.8
YoY
|
-
No YoY
|
|
YI
111, Inc.
|
35.28M
|
Composite
32.2
Moat
41.6
|
17.54
-438.3
YoY
|
-0.0%
-0.0
YoY
|
|
35.12M
|
Composite
39.2
Moat
46.4
|
1.59
-4.1
YoY
|
-1.1%
-42.5
YoY
|
|
|
NNVC
NanoViricides, Inc.
|
33.60M
|
Composite
55.1
Moat
26.8
|
2.21
-6.9
YoY
|
-
No YoY
|
|
NSPR
InspireMD Inc.
|
32.50M
|
Composite
44.3
Moat
21.9
|
18.53
-0.5
YoY
|
-5.5%
-0.7
YoY
|
|
31.75M
|
Composite
42.5
Moat
39.4
|
0.43
-10.3
YoY
|
-
No YoY
|
|
|
ARAY
Accuray Incorporated
|
31.41M
|
Composite
42.9
Moat
51.7
|
69.12
-374.6
YoY
|
1.7%
+1.6
YoY
|
|
31.27M
|
Composite
42.3
Moat
41.1
|
4.58
-8.8
YoY
|
-63.5%
+14.8
YoY
|
|
|
31.14M
|
Composite
41.4
Moat
22.3
|
4.54
-9.5
YoY
|
-2896.7%
-2862.9
YoY
|
|
|
30.43M
|
Composite
44.7
Moat
29.8
|
23.43
-3.0
YoY
|
-402.7%
+238.2
YoY
|
|
|
30.40M
|
Composite
50.9
Moat
34.1
|
30.00
+26.8
YoY
|
-13.2%
+2383.8
YoY
|
|
|
30.00M
|
Composite
48.8
Moat
23.7
|
3.19
+0.6
YoY
|
-304.4%
-303.4
YoY
|
|
|
29.43M
|
Composite
51.1
Moat
15.0
|
8.22
+3.5
YoY
|
-
No YoY
|
|
|
29.20M
|
Composite
48.5
Moat
38.3
|
12.01
-7.4
YoY
|
-107.1%
-84.7
YoY
|
|
|
28.50M
|
Composite
41.0
Moat
65.9
|
-
No YoY
|
15.3%
+3.5
YoY
|
|
|
28.10M
|
Composite
41.1
Moat
51.0
|
-
No YoY
|
0.1%
+6.7
YoY
|
|
|
FGEN
FibroGen, Inc
|
27.90M
|
Composite
56.5
Moat
53.7
|
4.39
-3.4
YoY
|
-4.4%
+2.2
YoY
|
|
IGC
IGC Pharma, Inc.
|
27.90M
|
Composite
52.1
Moat
43.4
|
1.20
-1.6
YoY
|
-5.9%
+1.4
YoY
|
|
27.53M
|
Composite
53.5
Moat
47.5
|
4.97
+0.9
YoY
|
-
No YoY
|
|
|
PLRZ
Polyrizon Ltd.
|
26.88M
|
Composite
52.7
Moat
48.3
|
33.03
+6.3
YoY
|
-
No YoY
|
|
EVAX
Evaxion Biotech A/S
|
26.69M
|
Composite
57.5
Moat
61.0
|
42.08
+36.6
YoY
|
-1.2%
+3.2
YoY
|
|
26.51M
|
Composite
55.9
Moat
50.9
|
16.05
-5.1
YoY
|
-68.7%
-65.3
YoY
|
|
|
NKGN
NKGen Biotech, Inc.
|
26.12M
|
Composite
44.4
Moat
26.5
|
0.01
-0.0
YoY
|
-316.2%
-264.9
YoY
|
|
26.06M
|
Composite
50.7
Moat
54.9
|
17.62
-28.3
YoY
|
-3.5%
+96.9
YoY
|
|
|
25.94M
|
Composite
44.0
Moat
27.5
|
18.53
-5.9
YoY
|
-74.5%
-73.5
YoY
|
|
|
25.90M
|
Composite
42.5
Moat
32.7
|
5.92
+0.9
YoY
|
-78.3%
-49.7
YoY
|
|
|
25.86M
|
Composite
47.5
Moat
45.6
|
27.79
+26.2
YoY
|
-46.5%
-43.0
YoY
|
|
|
MEIP
MEI Pharma, Inc.
|
25.70M
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
25.45M
|
Composite
37.8
Moat
36.9
|
0.26
-3.7
YoY
|
-
No YoY
|
|
|
MDXH
MDxHealth SA
|
25.16M
|
Composite
42.7
Moat
52.9
|
159.2
+128.8
YoY
|
-14.2%
+12.4
YoY
|
|
KALA
KALA BIO, Inc.
|
25.10M
|
Composite
42.6
Moat
36.1
|
2.83
-18.1
YoY
|
-20.9%
-11.2
YoY
|
|
24.63M
|
Composite
44.0
Moat
27.1
|
7.17
-25.4
YoY
|
-
No YoY
|
|
|
LFWD
Lifeward Ltd.
|
23.75M
|
Composite
37.6
Moat
35.8
|
1.55
-2.2
YoY
|
-76.7%
-0.5
YoY
|
|
23.62M
|
Composite
47.8
Moat
56.5
|
1.28
-0.3
YoY
|
-
No YoY
|
|
|
AYTU
Aytu BioPharma, Inc.
|
23.60M
|
Composite
40.9
Moat
48.1
|
191.8
+18.8
YoY
|
3.8%
+3.0
YoY
|
|
23.59M
|
Composite
51.2
Moat
40.4
|
7.68
+4.7
YoY
|
-
No YoY
|
|
|
23.36M
|
Composite
43.1
Moat
48.8
|
6.06
+3.3
YoY
|
-38.4%
+7.8
YoY
|
|
|
23.04M
|
Composite
42.3
Moat
36.3
|
5.91
+3.4
YoY
|
-
No YoY
|
|
|
TXMD
TherapeuticsMD, Inc.
|
22.80M
|
Composite
67.7
Moat
47.0
|
2.25
-3.2
YoY
|
-1.4%
+1.4
YoY
|
|
22.41M
|
Composite
49.6
Moat
42.3
|
10.51
-11.2
YoY
|
-52.2%
+34.9
YoY
|
|
|
22.20M
|
Composite
47.3
Moat
42.9
|
455.2
+441.2
YoY
|
-6.8%
-7.4
YoY
|
|
|
22.14M
|
Composite
45.0
Moat
19.1
|
6.85
+1.0
YoY
|
-
No YoY
|
|
|
21.98M
|
Composite
33.2
Moat
28.9
|
3.51
-6.5
YoY
|
-
No YoY
|
|
|
CELU
Celularity Inc.
|
21.65M
|
Composite
43.1
Moat
57.5
|
5.59
+4.2
YoY
|
-2.3%
+68.8
YoY
|
|
21.19M
|
Composite
33.5
Moat
24.2
|
17.71
+7.1
YoY
|
-52.0%
-50.6
YoY
|
|
|
20.86M
|
Composite
32.1
Moat
29.0
|
62.80
+16.5
YoY
|
-37.3%
+8.7
YoY
|
|
|
LGVN
Longeveron Inc.
|
20.55M
|
Composite
53.2
Moat
32.8
|
3.00
-13.6
YoY
|
-19.4%
-12.5
YoY
|
|
LPCN
Lipocine Inc.
|
20.36M
|
Composite
46.5
Moat
40.7
|
18.36
-194.2
YoY
|
-5.2%
+5.1
YoY
|
|
20.32M
|
Composite
48.0
Moat
38.4
|
16.65
-23.9
YoY
|
-
No YoY
|
|
|
19.70M
|
Composite
54.6
Moat
35.3
|
10.57
+9.2
YoY
|
-9.9%
+122.3
YoY
|
|
|
IRIX
IRIDEX Corporation
|
19.50M
|
Composite
47.2
Moat
41.1
|
34.20
+30.3
YoY
|
-4.9%
+12.2
YoY
|
|
PLUR
Pluri Inc.
|
19.21M
|
Composite
42.3
Moat
38.2
|
13.58
-6.4
YoY
|
-16.6%
+51.4
YoY
|
|
19.09M
|
Composite
51.7
Moat
24.4
|
11.89
-1.6
YoY
|
-39.4%
No YoY
|
|
|
18.97M
|
Composite
56.5
Moat
59.7
|
10.31
+0.4
YoY
|
-7.2%
+73.7
YoY
|
|
|
18.45M
|
Composite
50.0
Moat
45.8
|
1.44
-2.2
YoY
|
-6.7%
+0.2
YoY
|
|
|
18.39M
|
Composite
47.2
Moat
32.4
|
11.35
-12.4
YoY
|
-39.0%
-37.0
YoY
|
|
|
18.14M
|
Composite
45.8
Moat
35.9
|
7.88
-4.2
YoY
|
-
No YoY
|
|
|
17.10M
|
Composite
52.5
Moat
53.8
|
5.14
-10.2
YoY
|
-
No YoY
|
|
|
BIVI
BioVie Inc.
|
16.89M
|
Composite
51.8
Moat
36.4
|
11.07
+0.8
YoY
|
-
No YoY
|
|
16.71M
|
Composite
55.8
Moat
43.7
|
43.51
+37.5
YoY
|
-299.3%
No YoY
|
|
|
16.67M
|
Composite
59.8
Moat
59.7
|
11.73
+2.8
YoY
|
-2.4%
-0.6
YoY
|
|
|
AIMD
Ainos, Inc.
|
16.30M
|
Composite
37.5
Moat
33.8
|
1.09
-7.0
YoY
|
-112.7%
+555.0
YoY
|
|
GTBP
GT Biopharma, Inc.
|
16.13M
|
Composite
57.2
Moat
16.9
|
6.33
+2.7
YoY
|
-
No YoY
|
|
15.40M
|
Composite
50.8
Moat
42.9
|
1.92
+0.5
YoY
|
-
No YoY
|
|
|
MLEC
Moolec Science SA
|
15.25M
|
Composite
47.9
Moat
64.1
|
0.83
-6.1
YoY
|
-1.1%
-10.0
YoY
|
|
15.20M
|
Composite
40.9
Moat
37.3
|
2.26
-13.6
YoY
|
-16.8%
-4.4
YoY
|
|
|
FLGC
Flora Growth Corp.
|
15.02M
|
Composite
48.0
Moat
24.4
|
14.35
+8.1
YoY
|
-21.8%
-7.9
YoY
|
|
CALC
CalciMedica, Inc.
|
15.01M
|
Composite
48.4
Moat
22.4
|
7.38
-3.2
YoY
|
-
No YoY
|
|
14.95M
|
Composite
57.5
Moat
43.1
|
266.0
No YoY
|
2.9%
-12.5
YoY
|
|
|
PASG
Passage Bio, Inc.
|
14.79M
|
Composite
54.8
Moat
34.5
|
17.63
-1.6
YoY
|
-
No YoY
|
|
14.62M
|
Composite
44.3
Moat
22.3
|
3.45
-7.5
YoY
|
-
No YoY
|
|
|
BFRI
Biofrontera Inc.
|
14.60M
|
Composite
41.5
Moat
37.7
|
5.75
-1.2
YoY
|
-27.2%
+18.9
YoY
|
|
14.41M
|
Composite
53.3
Moat
35.7
|
4.46
-9.3
YoY
|
-
No YoY
|
|
|
COSM
Cosmos Health Inc.
|
14.20M
|
Composite
32.3
Moat
21.1
|
1.08
+0.6
YoY
|
-25.3%
+2.7
YoY
|
|
13.93M
|
Composite
51.4
Moat
28.6
|
10.29
+3.1
YoY
|
-
No YoY
|
|
|
HOOK
HOOKIPA Pharma Inc.
|
13.86M
|
Composite
57.0
Moat
59.2
|
6.19
-18.2
YoY
|
-85.1%
-81.4
YoY
|
|
INAB
IN8bio, Inc.
|
13.79M
|
Composite
58.4
Moat
47.6
|
25.57
+20.0
YoY
|
-
No YoY
|
|
13.67M
|
Composite
36.7
Moat
15.6
|
4.75
-6.9
YoY
|
-56.5%
+26.1
YoY
|
|
|
13.53M
|
Composite
33.0
Moat
19.0
|
5.97
+5.7
YoY
|
-37.6%
+69.9
YoY
|
|
|
ICCM
IceCure Medical Ltd.
|
13.33M
|
Composite
41.2
Moat
30.2
|
7.33
+0.1
YoY
|
-4.5%
+0.3
YoY
|
|
13.27M
|
Composite
54.7
Moat
32.5
|
15.49
+13.5
YoY
|
-
No YoY
|
|
|
AEON
AEON Biopharma, Inc.
|
13.22M
|
Composite
43.4
Moat
64.7
|
2.08
+2.1
YoY
|
-
No YoY
|
|
13.18M
|
Composite
47.1
Moat
46.3
|
11.18
+0.0
YoY
|
-
No YoY
|
|
|
13.08M
|
Composite
31.7
Moat
37.5
|
14.15
+12.5
YoY
|
-1.2%
+1.3
YoY
|
|
|
13.05M
|
Composite
57.5
Moat
50.4
|
21.98
+17.4
YoY
|
-
No YoY
|
|
|
BLRX
BioLineRx Ltd.
|
13.05M
|
Composite
57.6
Moat
46.5
|
31.03
+25.7
YoY
|
-8.7%
+57.5
YoY
|
|
13.02M
|
Composite
48.6
Moat
30.7
|
4.69
+2.5
YoY
|
-
No YoY
|
|
|
12.70M
|
Composite
27.8
Moat
16.1
|
3.44
-9.1
YoY
|
-
No YoY
|
|
|
12.57M
|
Composite
38.2
Moat
18.0
|
10.80
+2.4
YoY
|
-232.3%
-139.1
YoY
|
|
|
XCUR
Exicure, Inc.
|
12.11M
|
Composite
40.9
Moat
43.3
|
5.25
-46.3
YoY
|
-9.9%
-3.5
YoY
|
|
12.08M
|
Composite
52.8
Moat
62.8
|
31.63
+22.5
YoY
|
-
No YoY
|
|
|
FEMY
Femasys Inc.
|
11.63M
|
Composite
44.0
Moat
43.0
|
5.95
+3.8
YoY
|
-7.7%
+3.2
YoY
|
|
RENB
Renovaro Inc.
|
11.60M
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
11.60M
|
Composite
50.1
Moat
40.7
|
6.80
-15.2
YoY
|
-13.1%
+32.0
YoY
|
|
|
11.30M
|
Composite
57.9
Moat
69.2
|
20.59
+17.5
YoY
|
34.9%
No YoY
|
|
|
11.18M
|
Composite
45.2
Moat
37.8
|
10.97
-8.7
YoY
|
-
No YoY
|
|
|
VNRX
VolitionRX Limited
|
11.16M
|
Composite
37.3
Moat
60.9
|
0.68
-0.8
YoY
|
-12.3%
+9.5
YoY
|
|
10.76M
|
Composite
53.0
Moat
32.9
|
9.40
+1.2
YoY
|
-
No YoY
|
|
|
10.65M
|
Composite
42.3
Moat
40.1
|
18.85
No YoY
|
1.0%
-9.0
YoY
|
|
|
IMRN
Immuron Limited
|
10.30M
|
Composite
48.9
Moat
54.0
|
5.53
-18.3
YoY
|
-73.5%
-72.4
YoY
|
|
TRAW
Traws Pharma, Inc.
|
10.23M
|
Composite
50.9
Moat
45.5
|
2.52
-6.1
YoY
|
-6.4%
+103.8
YoY
|
|
BCDA
BioCardia, Inc.
|
10.15M
|
Composite
38.3
Moat
12.8
|
4.03
+0.4
YoY
|
-137.9%
-113.5
YoY
|
|
10.04M
|
Composite
46.9
Moat
34.9
|
-
No YoY
|
-7.2%
-13.4
YoY
|
|
|
9.74M
|
Composite
39.6
Moat
42.3
|
9.01
-1.6
YoY
|
-27.8%
+18.1
YoY
|
|
|
CRIS
Curis, Inc.
|
9.67M
|
Composite
48.9
Moat
57.7
|
2.23
-3.8
YoY
|
-3.5%
+0.6
YoY
|
|
9.63M
|
Composite
38.0
Moat
29.7
|
8.20
-14.7
YoY
|
-56.8%
+58.3
YoY
|
|
|
CODX
Co-Diagnostics, Inc.
|
9.50M
|
Composite
38.3
Moat
26.5
|
4.89
-7.3
YoY
|
-50.3%
-40.0
YoY
|
|
9.48M
|
Composite
51.0
Moat
34.0
|
16.61
-4.9
YoY
|
-
No YoY
|
|
|
9.12M
|
Composite
44.0
Moat
24.5
|
10.95
+5.7
YoY
|
-
No YoY
|
|
|
9.01M
|
Composite
61.0
Moat
35.9
|
13.59
-6.6
YoY
|
-
No YoY
|
|
|
MTVA
MetaVia Inc.
|
8.93M
|
Composite
60.6
Moat
35.5
|
7.86
+0.1
YoY
|
-
No YoY
|
|
8.80M
|
Composite
46.7
Moat
28.6
|
3.28
-12.4
YoY
|
-43.5%
-14.7
YoY
|
|
|
8.63M
|
Composite
39.8
Moat
17.3
|
3.82
-12.5
YoY
|
-
No YoY
|
|
|
8.61M
|
Composite
49.7
Moat
51.5
|
0.05
-0.2
YoY
|
-
No YoY
|
|
|
HSCS
HeartSciences Inc.
|
8.54M
|
Composite
38.0
Moat
17.0
|
1.78
-9.7
YoY
|
-1920.1%
-1581.1
YoY
|
|
8.51M
|
Composite
42.1
Moat
18.9
|
8.40
-3.2
YoY
|
-408.7%
-394.0
YoY
|
|
|
YCBD
cbdMD, Inc.
|
8.50M
|
Composite
40.7
Moat
40.4
|
18.68
-64.7
YoY
|
-11.3%
+5.8
YoY
|
|
IMNN
Imunon, Inc.
|
8.40M
|
Composite
52.6
Moat
37.1
|
7.58
+3.8
YoY
|
-49.8%
-7.8
YoY
|
|
XWEL
XWELL, Inc.
|
8.40M
|
Composite
28.4
Moat
41.3
|
3.61
-9.2
YoY
|
-32.0%
+3.7
YoY
|
|
SYBX
Synlogic, Inc.
|
8.19M
|
Composite
47.0
Moat
28.1
|
40.38
+33.2
YoY
|
-1972.1%
-1955.8
YoY
|
|
TRIB
Trinity Biotech plc
|
7.92M
|
Composite
33.7
Moat
46.0
|
10.40
-4.4
YoY
|
-26.1%
-3.8
YoY
|
|
KAPA
Kairos Pharma, Ltd.
|
7.92M
|
Composite
59.5
Moat
45.4
|
15.66
+11.8
YoY
|
-
No YoY
|
|
7.92M
|
Composite
42.7
Moat
71.6
|
0.46
-4.6
YoY
|
-
No YoY
|
|
|
AKAN
Akanda Corp.
|
7.90M
|
Composite
24.3
Moat
18.7
|
0.90
-10.7
YoY
|
-19.3%
-14.1
YoY
|
|
7.77M
|
Composite
40.5
Moat
13.2
|
6.26
+1.7
YoY
|
-
No YoY
|
|
|
7.65M
|
Composite
44.0
Moat
51.5
|
8.28
-1.0
YoY
|
-4.5%
+4.4
YoY
|
|
|
7.56M
|
Composite
40.7
Moat
42.1
|
11.45
-0.9
YoY
|
-24.6%
-12.5
YoY
|
|
|
7.50M
|
Composite
57.1
Moat
74.7
|
62.61
-217.3
YoY
|
-
No YoY
|
|
|
7.41M
|
Composite
41.5
Moat
25.8
|
17.11
+5.8
YoY
|
-1.6%
+0.2
YoY
|
|
|
7.34M
|
Composite
39.4
Moat
36.1
|
21.75
-9.0
YoY
|
-
No YoY
|
|
|
7.34M
|
Composite
35.8
Moat
32.1
|
9.09
+1.6
YoY
|
-93.9%
-87.1
YoY
|
|
|
7.30M
|
Composite
32.4
Moat
13.6
|
5.80
+0.8
YoY
|
-14.7%
-7.5
YoY
|
|
|
ACON
Aclarion, Inc.
|
7.17M
|
Composite
39.9
Moat
11.2
|
20.13
+19.1
YoY
|
-93.1%
+27.4
YoY
|
|
7.04M
|
Composite
52.8
Moat
15.5
|
7.04
+2.2
YoY
|
-
No YoY
|
|
|
6.97M
|
Composite
28.0
Moat
15.4
|
1.77
-3.5
YoY
|
-
No YoY
|
|
|
6.92M
|
Composite
43.6
Moat
21.8
|
3.22
+1.9
YoY
|
-29.6%
+274.4
YoY
|
|
|
PULM
Pulmatrix, Inc.
|
6.57M
|
Composite
54.5
Moat
55.6
|
9.03
-1.6
YoY
|
-91.5%
-89.5
YoY
|
|
6.52M
|
Composite
46.2
Moat
39.3
|
1.69
-6.8
YoY
|
-4.8%
No YoY
|
|
|
6.47M
|
Composite
34.9
Moat
35.4
|
1.60
-4.3
YoY
|
-1.1%
+73.2
YoY
|
|
|
NXTC
NextCure, Inc.
|
6.43M
|
Composite
55.4
Moat
42.7
|
10.11
-10.1
YoY
|
-
No YoY
|
|
MGRX
Mangoceuticals, Inc.
|
6.42M
|
Composite
31.7
Moat
19.4
|
3.05
+2.9
YoY
|
-42.0%
-27.9
YoY
|
|
6.41M
|
Composite
31.3
Moat
16.7
|
2.61
-9.2
YoY
|
-
No YoY
|
|
|
6.40M
|
Composite
47.7
Moat
38.6
|
3.34
+0.1
YoY
|
-132.5%
-16.2
YoY
|
|
|
6.39M
|
Composite
49.7
Moat
42.3
|
22.56
+13.7
YoY
|
-24.6%
-11.3
YoY
|
|
|
6.27M
|
Composite
56.9
Moat
19.0
|
13.36
+9.1
YoY
|
-
No YoY
|
|
|
PPBT
Purple Biotech Ltd.
|
6.22M
|
Composite
57.4
Moat
38.8
|
20.31
+13.2
YoY
|
-
No YoY
|
|
6.21M
|
Composite
65.9
Moat
69.6
|
41.37
+15.1
YoY
|
-95.2%
-93.5
YoY
|
|
|
XAIR
Beyond Air, Inc.
|
6.16M
|
Composite
32.9
Moat
31.2
|
7.70
+5.5
YoY
|
-3.8%
+8.2
YoY
|
|
GELS
Gelteq Limited
|
6.09M
|
Composite
37.3
Moat
26.5
|
0.75
+0.5
YoY
|
-29.9%
+12.4
YoY
|
|
PTHL
Pheton Holdings Ltd
|
6.01M
|
Composite
42.9
Moat
40.7
|
95.38
+54.3
YoY
|
-1.5%
+39.7
YoY
|
|
6.00M
|
Composite
45.9
Moat
34.8
|
10.87
+4.4
YoY
|
-
No YoY
|
|
|
BCAB
BioAtla, Inc.
|
5.96M
|
Composite
43.4
Moat
43.9
|
1.77
-6.4
YoY
|
-29.7%
-22.9
YoY
|
|
5.93M
|
Composite
40.5
Moat
35.2
|
7.32
-725.5
YoY
|
-12.6%
+13.4
YoY
|
|
|
GNPX
Genprex, Inc.
|
5.88M
|
Composite
47.0
Moat
30.8
|
6.14
+5.1
YoY
|
-
No YoY
|
|
5.68M
|
Composite
47.9
Moat
31.9
|
10.71
-8.1
YoY
|
-437.4%
-197.6
YoY
|
|
|
MBIO
Mustang Bio, Inc.
|
5.61M
|
Composite
53.9
Moat
29.7
|
39.36
+32.2
YoY
|
-
No YoY
|
|
HCWB
HCW Biologics Inc.
|
5.54M
|
Composite
62.6
Moat
28.0
|
1.75
-2.2
YoY
|
-207.6%
-196.8
YoY
|
|
SNGX
Soligenix, Inc.
|
5.50M
|
Composite
43.8
Moat
18.4
|
9.28
-1.9
YoY
|
-56.4%
+331.1
YoY
|
|
5.42M
|
Composite
51.4
Moat
21.4
|
5.84
+4.6
YoY
|
-
No YoY
|
|
|
5.39M
|
Composite
57.8
Moat
30.1
|
11.64
+8.2
YoY
|
-
No YoY
|
|
|
5.29M
|
Composite
40.5
Moat
30.4
|
1.26
-6.6
YoY
|
-3.4%
-0.1
YoY
|
|
|
5.27M
|
Composite
46.0
Moat
31.2
|
6.89
+3.4
YoY
|
-
No YoY
|
|
|
5.20M
|
Composite
45.0
Moat
38.0
|
7.12
-3.0
YoY
|
-4.8%
+28.7
YoY
|
|
|
NCNA
NuCana plc
|
5.16M
|
Composite
64.8
Moat
39.3
|
38.97
+34.7
YoY
|
-
No YoY
|
|
BMRA
Biomerica, Inc.
|
5.13M
|
Composite
38.4
Moat
35.9
|
7.49
-1.8
YoY
|
-96.7%
-95.5
YoY
|
|
VSEE
VSee Health, Inc.
|
5.10M
|
Composite
38.3
Moat
20.1
|
18.34
+17.7
YoY
|
-65.5%
-20.6
YoY
|
|
5.07M
|
Composite
45.4
Moat
15.4
|
11.12
+4.2
YoY
|
-959.8%
-920.8
YoY
|
|
|
4.91M
|
Composite
49.3
Moat
49.0
|
10.14
+5.7
YoY
|
-9.2%
-7.5
YoY
|
|
|
4.90M
|
Composite
48.0
Moat
26.3
|
5.79
+3.2
YoY
|
-845.0%
-363.8
YoY
|
|
|
ELAB
PMGC Holdings Inc.
|
4.82M
|
Composite
52.5
Moat
37.3
|
12.08
+3.4
YoY
|
-11.6%
-9.2
YoY
|
|
NXGL
NexGel, Inc
|
4.70M
|
Composite
34.2
Moat
39.4
|
2.90
-2.7
YoY
|
-29.3%
+11.6
YoY
|
|
FBLG
FibroBiologics, Inc.
|
4.65M
|
Composite
45.3
Moat
15.3
|
14.10
-3.1
YoY
|
-
No YoY
|
|
EVGN
Evogene Ltd.
|
4.60M
|
Composite
51.7
Moat
53.7
|
11.51
+2.2
YoY
|
-3.6%
-0.3
YoY
|
|
4.40M
|
Composite
38.6
Moat
23.5
|
0.83
+0.2
YoY
|
-2.3%
+19.1
YoY
|
|
|
4.35M
|
Composite
46.6
Moat
49.1
|
6.61
-11.9
YoY
|
-1.4%
+73.2
YoY
|
|
|
ALZN
Alzamend Neuro, Inc.
|
4.34M
|
Composite
53.2
Moat
21.6
|
7.21
+6.7
YoY
|
-
No YoY
|
|
PRFX
PainReform Ltd.
|
4.32M
|
Composite
33.9
Moat
9.6
|
12.56
+8.5
YoY
|
-301.3%
No YoY
|
|
MYNZ
Mainz Biomed N.V.
|
4.28M
|
Composite
26.9
Moat
36.5
|
4.38
+0.5
YoY
|
-20.6%
+9.2
YoY
|
|
4.17M
|
Composite
49.6
Moat
51.5
|
10.81
+3.5
YoY
|
-
No YoY
|
|
|
4.15M
|
Composite
52.0
Moat
39.9
|
2.65
-0.9
YoY
|
-7.7%
+8.3
YoY
|
|
|
4.07M
|
Composite
41.7
Moat
14.9
|
6.63
+1.0
YoY
|
-
No YoY
|
|
|
GOVX
GeoVax Labs, Inc.
|
4.06M
|
Composite
40.3
Moat
37.9
|
1.72
-1.0
YoY
|
-8.7%
-2.3
YoY
|
|
4.02M
|
Composite
33.0
Moat
11.6
|
12.57
+0.7
YoY
|
-46.4%
-45.2
YoY
|
|
|
TNON
Tenon Medical, Inc.
|
4.01M
|
Composite
39.2
Moat
33.0
|
4.19
-3.7
YoY
|
-3.2%
+1.0
YoY
|
|
3.90M
|
Composite
48.3
Moat
41.3
|
6.84
+1.3
YoY
|
-21.7%
-14.0
YoY
|
|
|
3.87M
|
Composite
32.9
Moat
13.4
|
5.54
+5.3
YoY
|
-70.3%
-31.2
YoY
|
|
|
3.81M
|
Composite
48.8
Moat
25.4
|
15.53
+11.3
YoY
|
-
No YoY
|
|
|
3.75M
|
Composite
60.2
Moat
44.7
|
34.50
+3.2
YoY
|
-
No YoY
|
|
|
3.72M
|
Composite
58.7
Moat
32.5
|
6.46
+0.9
YoY
|
-
No YoY
|
|
|
3.69M
|
Composite
41.6
Moat
43.8
|
0.13
-3.6
YoY
|
-14.9%
+11.9
YoY
|
|
|
ONCO
Onconetix, Inc.
|
3.64M
|
Composite
44.0
Moat
39.9
|
6.47
+5.7
YoY
|
-7.8%
-3.7
YoY
|
|
3.60M
|
Composite
35.1
Moat
19.0
|
4.94
-1.0
YoY
|
-27.7%
-26.1
YoY
|
|
|
3.56M
|
Composite
52.5
Moat
35.8
|
0.85
-2.5
YoY
|
-
No YoY
|
|
|
3.53M
|
Composite
30.1
Moat
28.1
|
8.30
+6.5
YoY
|
-1.7%
+93.9
YoY
|
|
|
3.51M
|
Composite
34.5
Moat
20.4
|
6.84
-6.4
YoY
|
-
No YoY
|
|
|
3.48M
|
Composite
45.4
Moat
35.0
|
79.79
+42.6
YoY
|
-16.3%
+18.5
YoY
|
|
|
3.48M
|
Composite
45.8
Moat
26.0
|
14.77
+1.3
YoY
|
-1023.8%
-501.6
YoY
|
|
|
3.46M
|
Composite
38.7
Moat
30.8
|
20.54
+11.3
YoY
|
-12.3%
+4.3
YoY
|
|
|
ISPC
iSpecimen Inc.
|
3.29M
|
Composite
27.3
Moat
13.5
|
19.47
+16.7
YoY
|
-4.7%
-3.3
YoY
|
|
GRI
GRI Bio, Inc.
|
3.15M
|
Composite
46.0
Moat
15.6
|
9.69
+2.7
YoY
|
-
No YoY
|
|
SPRC
SciSparc Ltd.
|
3.12M
|
Composite
39.3
Moat
37.5
|
13.32
+8.5
YoY
|
-10.2%
-4.7
YoY
|
|
3.08M
|
Composite
47.0
Moat
16.4
|
14.16
-2.8
YoY
|
-
No YoY
|
|
|
SNYR
Synergy CHC Corp.
|
3.00M
|
Composite
25.1
Moat
40.9
|
12.17
+10.5
YoY
|
-5.9%
-22.6
YoY
|
|
2.91M
|
Composite
45.2
Moat
14.4
|
3.16
-2.7
YoY
|
-514.0%
-490.6
YoY
|
|
|
PHGE
BiomX Inc.
|
2.84M
|
Composite
44.0
Moat
34.9
|
1.98
-3.5
YoY
|
-
No YoY
|
|
VCNX
Vaccinex, Inc.
|
2.81M
|
Composite
37.6
Moat
37.6
|
0.82
-0.0
YoY
|
-31.2%
+9.0
YoY
|
|
OGEN
Oragenics Inc.
|
2.60M
|
Composite
60.1
Moat
36.5
|
10.90
+9.7
YoY
|
-
No YoY
|
|
BBLG
Bone Biologics Corp
|
2.48M
|
Composite
55.7
Moat
26.1
|
23.79
+14.1
YoY
|
-
No YoY
|
|
GCTK
GlucoTrack, Inc.
|
2.43M
|
Composite
24.9
Moat
24.4
|
5.81
+0.4
YoY
|
-
No YoY
|
|
AZTR
Azitra Inc
|
2.41M
|
Composite
41.4
Moat
21.7
|
2.21
-3.2
YoY
|
-1464.7%
-1453.8
YoY
|
|
SYRA
Syra Health Corp.
|
2.27M
|
Composite
54.5
Moat
25.3
|
43.28
+33.5
YoY
|
-12.5%
+34.7
YoY
|
|
2.15M
|
Composite
44.1
Moat
36.6
|
18.32
+16.7
YoY
|
-21.0%
-8.3
YoY
|
|
|
2.15M
|
Composite
48.1
Moat
46.2
|
9.73
-9.4
YoY
|
-17.4%
-14.3
YoY
|
|
|
2.01M
|
Composite
40.4
Moat
8.4
|
1.33
+0.2
YoY
|
-
No YoY
|
|
|
1.99M
|
Composite
46.2
Moat
68.3
|
1.16
+0.5
YoY
|
11.6%
No YoY
|
|
|
1.92M
|
Composite
31.6
Moat
5.0
|
0.42
-2.7
YoY
|
-
No YoY
|
|
|
1.76M
|
Composite
48.0
Moat
15.5
|
21.68
+17.5
YoY
|
-7.3%
-0.2
YoY
|
|
|
1.60M
|
Composite
32.1
Moat
42.5
|
8.62
-0.0
YoY
|
-20.7%
+14.7
YoY
|
|
|
1.45M
|
Composite
38.2
Moat
16.5
|
10.24
+3.6
YoY
|
-37.4%
No YoY
|
|
|
JAGX
Jaguar Health, Inc.
|
1.45M
|
Composite
57.6
Moat
46.7
|
0.49
-2.8
YoY
|
-3.9%
-1.3
YoY
|
|
1.28M
|
Composite
53.5
Moat
48.7
|
18.69
+15.2
YoY
|
-2.3%
No YoY
|
|
|
1.28M
|
Composite
42.1
Moat
26.2
|
5.23
-7.9
YoY
|
-
No YoY
|
|
|
1.09M
|
Composite
41.5
Moat
34.6
|
6.64
+4.9
YoY
|
-
No YoY
|
|
|
1.02M
|
Composite
54.8
Moat
34.0
|
3.30
-0.4
YoY
|
-5.8%
+7.4
YoY
|
|
|
IMCC
IM Cannabis Corp.
|
1.00M
|
Composite
34.8
Moat
30.0
|
9.62
+6.9
YoY
|
-21.2%
-2.2
YoY
|
|
890,551
|
Composite
37.6
Moat
53.7
|
0.24
-2.2
YoY
|
-
No YoY
|
|
|
843,068
|
Composite
43.4
Moat
37.1
|
6.61
-0.3
YoY
|
-74.3%
-34.7
YoY
|
|
|
LGMK
LogicMark, Inc.
|
674,819
|
Composite
38.5
Moat
32.1
|
22.55
+11.8
YoY
|
-69.1%
+8.3
YoY
|
|
631,573
|
Composite
50.0
Moat
61.3
|
1.24
-2.1
YoY
|
-
No YoY
|
|
|
VERO
Venus Concept Inc.
|
563,314
|
Composite
28.9
Moat
50.1
|
4.63
-0.4
YoY
|
-41.9%
-4.9
YoY
|
|
497,436
|
Composite
50.0
Moat
35.1
|
3.75
-4.3
YoY
|
-
No YoY
|
|
|
NOTV
Inotiv, Inc.
|
476,223
|
Composite
38.8
Moat
38.4
|
24.95
-12.8
YoY
|
-7.2%
+3.9
YoY
|
|
IOBT
IO Biotech, Inc.
|
467,667
|
Composite
49.0
Moat
33.7
|
8.75
-15.2
YoY
|
-
No YoY
|
|
441,572
|
Composite
47.9
Moat
20.0
|
6.71
+6.4
YoY
|
-
No YoY
|
|
|
373,266
|
Composite
45.0
Moat
25.5
|
0.64
+0.4
YoY
|
-21.4%
-19.9
YoY
|
|
|
337,087
|
Composite
34.5
Moat
40.0
|
1.39
-2.5
YoY
|
-
No YoY
|
|
|
PRPH
ProPhase Labs, Inc.
|
331,590
|
Composite
27.0
Moat
18.3
|
0.13
-0.3
YoY
|
-4.2%
+1.6
YoY
|
|
254,233
|
Composite
35.9
Moat
29.7
|
9.15
+1.2
YoY
|
-2.0%
-0.2
YoY
|
|
|
NUWE
Nuwellis, Inc.
|
242,087
|
Composite
35.3
Moat
42.9
|
1.20
-5.2
YoY
|
-1.3%
-0.1
YoY
|
|
191,166
|
Composite
36.9
Moat
7.6
|
0.05
-2.1
YoY
|
-
No YoY
|
|
|
161,729
|
Composite
47.1
Moat
34.1
|
6.64
-5.9
YoY
|
-9.5%
+1.1
YoY
|
|
|
104,612
|
Composite
56.2
Moat
51.5
|
3.59
-7.9
YoY
|
-3.2%
+2.8
YoY
|
|
|
92,946
|
Composite
38.6
Moat
61.1
|
0.00
-0.0
YoY
|
-
No YoY
|
|
|
MSPR
MSP Recovery, Inc.
|
85,646
|
Composite
28.4
Moat
14.4
|
9.18
+5.7
YoY
|
-28.6%
+44.1
YoY
|
|
ZCMD
Zhongchao Inc.
|
83,725
|
Composite
41.4
Moat
37.3
|
106.6
-111.7
YoY
|
-54.4%
-52.3
YoY
|
|
VINC
Vincerx Pharma, Inc.
|
65,428
|
Composite
41.9
Moat
16.4
|
2.29
-1.5
YoY
|
-
No YoY
|
|
WORX
SCWorx Corp.
|
40,009
|
Composite
43.3
Moat
34.1
|
12.78
+11.6
YoY
|
-33.3%
+8.8
YoY
|
|
32,385
|
Composite
44.1
Moat
44.7
|
33.98
-122.9
YoY
|
-19.0%
-4.1
YoY
|
|
|
24,642
|
Composite
54.2
Moat
53.7
|
35.32
+31.4
YoY
|
-9.1%
+23.1
YoY
|
|
|
TTOO
T2 Biosystems, Inc.
|
14,022
|
Composite
26.3
Moat
19.6
|
3.91
+1.5
YoY
|
-6.6%
-4.1
YoY
|
|
10,732
|
Composite
45.1
Moat
37.5
|
15.26
-4.5
YoY
|
-12.7%
-4.2
YoY
|
|
|
ADTX
Aditxt, Inc.
|
2,611
|
Composite
34.2
Moat
11.6
|
1.49
+0.9
YoY
|
-6125.4%
-5917.5
YoY
|
|
ICCT
iCoreConnect Inc.
|
2,438
|
Composite
28.2
Moat
31.1
|
0.75
-0.9
YoY
|
-1.4%
-0.2
YoY
|
|
940
|
Composite
40.1
Moat
43.1
|
7.46
-4.7
YoY
|
-
No YoY
|
|
|
DHAI
DIH Holding US, Inc.
|
837
|
Composite
46.0
Moat
48.4
|
0.21
-1.9
YoY
|
-7.7%
-3.7
YoY
|
|
BACK
IMAC Holdings, Inc.
|
756
|
Composite
22.7
Moat
20.3
|
1.91
+1.0
YoY
|
-78.0%
-8.9
YoY
|
|
OTRK
Ontrak, Inc.
|
708
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
124
|
Composite
32.5
Moat
33.0
|
1.09
-10.0
YoY
|
-
No YoY
|
|
|
-
|
Composite
58.4
Moat
78.1
|
3.10
-1.9
YoY
|
16.2%
+26.0
YoY
|
|
|
ABPWW
Abpro Holdings, Inc.
|
-
|
Composite
44.3
Moat
47.0
|
0.13
-3.7
YoY
|
-54.2%
+42.1
YoY
|
|
ACCD
Accolade, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
62.1
Moat
58.6
|
-
No YoY
|
-
No YoY
|
|
|
ACONW
Aclarion, Inc.
|
-
|
Composite
43.1
Moat
11.2
|
20.13
+19.1
YoY
|
-93.1%
+27.4
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
56.1
Moat
29.3
|
-
No YoY
|
-139.2%
-103.3
YoY
|
|
|
AFMD
Affimed N.V.
|
-
|
Composite
43.3
Moat
46.3
|
-
No YoY
|
-12.9%
-10.8
YoY
|
|
-
|
Composite
37.3
Moat
33.8
|
1.09
-7.0
YoY
|
-112.7%
+555.0
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
ALLK
Allakos Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
ALVOW
Alvotech Warrant
|
-
|
Composite
48.0
Moat
49.5
|
41.20
+38.6
YoY
|
13.3%
-0.9
YoY
|
|
ALVR
AlloVir, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
AMED
Amedisys Inc
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
40.7
Moat
39.5
|
176.3
+134.0
YoY
|
-0.9%
+0.5
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
48.9
Moat
13.1
|
11.30
+0.4
YoY
|
-229.2%
-222.8
YoY
|
|
|
-
|
Composite
43.4
Moat
64.9
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
ATNFW
180 Life Sciences Corp.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
70.6
Moat
30.3
|
18.87
+9.1
YoY
|
-25.1%
-20.1
YoY
|
|
|
AVGR
Avinger, Inc.
|
-
|
Composite
25.9
Moat
39.1
|
-
No YoY
|
-2.2%
-0.2
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
30.2
Moat
47.8
|
-
No YoY
|
-3.0%
+1.5
YoY
|
|
|
-
|
Composite
51.5
Moat
26.1
|
23.79
+14.1
YoY
|
-
No YoY
|
|
|
-
|
Composite
45.8
Moat
39.4
|
0.43
-10.3
YoY
|
-
No YoY
|
|
|
-
|
Composite
43.9
Moat
46.5
|
1.59
-4.1
YoY
|
-1.1%
-42.5
YoY
|
|
|
-
|
Composite
42.4
Moat
37.7
|
5.75
-1.2
YoY
|
-27.2%
+18.9
YoY
|
|
|
BGNE
BeiGene, Ltd.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
29.1
Moat
28.1
|
8.30
+6.5
YoY
|
-1.7%
+93.9
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
BLUE
bluebird bio, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
63.2
Moat
46.1
|
35.15
No YoY
|
1.8%
0.0
YoY
|
|
|
CANB
CAN B CORP.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
61.3
Moat
68.4
|
-
No YoY
|
9.5%
+0.8
YoY
|
|
|
-
|
Composite
56.4
Moat
64.6
|
-
No YoY
|
8.2%
+48.5
YoY
|
|
|
-
|
Composite
44.2
Moat
31.9
|
10.71
-8.1
YoY
|
-437.4%
-197.6
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
39.5
Moat
59.5
|
1.16
+0.5
YoY
|
-
No YoY
|
|
|
-
|
Composite
44.5
Moat
30.6
|
12.90
-6.2
YoY
|
-138.1%
-137.0
YoY
|
|
|
CELUW
Celularity Inc.
|
-
|
Composite
44.0
Moat
57.5
|
5.59
+4.2
YoY
|
-2.3%
+68.8
YoY
|
|
-
|
Composite
46.4
Moat
61.3
|
1.24
-2.1
YoY
|
-
No YoY
|
|
|
CHEK
Check-Cap Ltd.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
CINGW
Cingulate Inc. Warrants
|
-
|
Composite
57.2
Moat
14.5
|
7.62
-0.3
YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
CMRX
Chimerix, Inc.
|
-
|
Composite
48.7
Moat
29.3
|
-
No YoY
|
-455.5%
-168.3
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
CUTR
Cutera, Inc.
|
-
|
Composite
33.5
Moat
35.6
|
-
No YoY
|
-73.6%
-58.4
YoY
|
|
CYBN
Cybin Inc.
|
-
|
Composite
56.7
Moat
57.6
|
15.99
-20.4
YoY
|
-
No YoY
|
|
-
|
Composite
59.0
Moat
44.1
|
-
No YoY
|
-279.2%
-218.6
YoY
|
|
|
-
|
Composite
47.8
Moat
44.1
|
-
No YoY
|
-279.2%
-218.6
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
CYTHW
Cyclo Therapeutics, Inc.
|
-
|
Composite
29.4
Moat
20.9
|
-
No YoY
|
-18.6%
0.0
YoY
|
|
-
|
Composite
42.6
Moat
54.3
|
-
No YoY
|
-4.0%
-3.6
YoY
|
|
|
-
|
Composite
52.0
Moat
30.1
|
11.64
+8.2
YoY
|
-
No YoY
|
|
|
DRRX
DURECT Corporation
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
54.2
Moat
42.9
|
32.89
-3.3
YoY
|
-
No YoY
|
|
|
-
|
Composite
68.6
Moat
57.4
|
-
No YoY
|
-1.5%
+9.6
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
54.7
Moat
41.9
|
23.43
-35.8
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
EPIX
ESSA Pharma Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
42.7
Moat
16.8
|
3.11
-19.2
YoY
|
-
No YoY
|
|
|
ETNB
89bio, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
38.6
Moat
34.9
|
1.71
+0.3
YoY
|
-35.8%
+28.5
YoY
|
|
|
EVOK
Evoke Pharma, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
EYEN
Eyenovia, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
FNA
Paragon 28, Inc.
|
-
|
Composite
52.6
Moat
60.4
|
-
No YoY
|
-15.9%
+1.3
YoY
|
|
GBIO
Generation Bio Co.
|
-
|
Composite
53.5
Moat
56.5
|
25.10
-35.0
YoY
|
-4.0%
+19.5
YoY
|
|
-
|
Composite
16.7
Moat
25.4
|
-
No YoY
|
-85.3%
-84.3
YoY
|
|
|
GLYC
GlycoMimetics, Inc.
|
-
|
Composite
48.3
Moat
31.6
|
-
No YoY
|
-3927.5%
-3294.9
YoY
|
|
GNFT
GENFIT S.A.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
GOVXW
GeoVax Labs, Inc.
|
-
|
Composite
38.6
Moat
37.9
|
1.72
-1.0
YoY
|
-8.7%
-2.3
YoY
|
|
HLVX
HilleVax, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
36.1
Moat
17.0
|
1.78
-9.7
YoY
|
-1920.1%
-1581.1
YoY
|
|
|
HUMAW
Humacyte, Inc.
|
-
|
Composite
45.9
Moat
32.0
|
5.77
+0.3
YoY
|
-53.1%
No YoY
|
|
ICAD
icad inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
32.1
Moat
11.1
|
3.84
-3.6
YoY
|
-47.1%
No YoY
|
|
|
IKNA
Ikena Oncology, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
IMAB
I-MAB
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
IMTXW
Immatics N.V.
|
-
|
Composite
49.6
Moat
54.4
|
31.89
-14.0
YoY
|
-3.8%
+21.0
YoY
|
|
INZY
Inozyme Pharma, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
49.8
Moat
35.7
|
4.46
-9.3
YoY
|
-
No YoY
|
|
|
KDLY
Kindly MD, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
KDLYW
Kindly MD, Inc. Warrants
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
53.7
Moat
21.5
|
0.26
+0.2
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
KRON
Kronos Bio, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
53.3
Moat
43.7
|
43.51
+37.5
YoY
|
-299.3%
No YoY
|
|
|
LEXXW
Lexaria Bioscience Corp.
|
-
|
Composite
40.1
Moat
41.5
|
2.26
-13.6
YoY
|
-16.8%
-4.4
YoY
|
|
-
|
Composite
44.5
Moat
42.2
|
2.07
-12.9
YoY
|
-4.0%
+9.2
YoY
|
|
|
-
|
Composite
49.6
Moat
38.2
|
19.96
+16.0
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
61.5
Moat
68.0
|
-
No YoY
|
-14.0%
+63.7
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
39.6
Moat
33.9
|
-
No YoY
|
-1.5%
-0.4
YoY
|
|
|
-
|
Composite
41.0
Moat
62.1
|
-
No YoY
|
14.8%
-0.3
YoY
|
|
|
-
|
Composite
50.0
Moat
64.1
|
0.83
-6.1
YoY
|
-1.1%
-10.0
YoY
|
|
|
MODV
ModivCare Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
MRUS
Merus N.V.
|
-
|
Composite
51.8
Moat
54.6
|
34.68
+4.8
YoY
|
-7.5%
-4.0
YoY
|
|
MSPRW
MSP Recovery, Inc.
|
-
|
Composite
28.2
Moat
14.4
|
9.18
+5.7
YoY
|
-28.6%
+44.1
YoY
|
|
MSPRZ
MSP Recovery, Inc.
|
-
|
Composite
28.2
Moat
14.4
|
9.18
+5.7
YoY
|
-28.6%
+44.1
YoY
|
|
MURA
Mural Oncology plc
|
-
|
Composite
54.4
Moat
47.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
52.9
Moat
48.4
|
51.66
-11.5
YoY
|
-10.0%
-6.2
YoY
|
|
|
NAOV
NanoVibronix, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
NARI
Inari Medical, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
NEUE
NeueHealth, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
48.1
Moat
23.5
|
0.83
+0.2
YoY
|
-2.3%
+19.1
YoY
|
|
|
-
|
Composite
41.3
Moat
26.5
|
0.01
-0.0
YoY
|
-316.2%
-264.9
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
NLSPW
NLS Pharmaceutics Ltd.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
32.7
Moat
36.9
|
0.26
-3.7
YoY
|
-
No YoY
|
|
|
-
|
Composite
48.5
Moat
42.4
|
6.63
+5.0
YoY
|
-13.2%
No YoY
|
|
|
NTRBW
Nutriband Inc. Warrant
|
-
|
Composite
45.4
Moat
47.3
|
10.69
-0.5
YoY
|
-4.1%
-1.0
YoY
|
|
NURO
NeuroMetrix, Inc.
|
-
|
Composite
38.1
Moat
32.1
|
-
No YoY
|
-2.9%
-1.7
YoY
|
|
NVRO
Nevro Corp.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
NXGLW
NexGel, Inc Warrant
|
-
|
Composite
36.4
Moat
39.4
|
2.90
-2.7
YoY
|
-29.3%
+11.6
YoY
|
|
NXLIW
Nexalin Technology, Inc.
|
-
|
Composite
38.7
Moat
43.0
|
9.01
-1.6
YoY
|
-27.8%
+18.1
YoY
|
|
OABIW
OmniAb, Inc.
|
-
|
Composite
60.9
Moat
60.2
|
17.78
-0.2
YoY
|
-3.7%
-0.9
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
34.6
Moat
46.1
|
-
No YoY
|
2.8%
-0.2
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
50.1
Moat
34.7
|
-
No YoY
|
-53.1%
-23.0
YoY
|
|
|
ONMDW
OneMedNet Corporation
|
-
|
Composite
30.9
Moat
17.3
|
1.74
-3.5
YoY
|
-7.1%
+7.8
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
OPT
Opthea Limited
|
-
|
Composite
33.0
Moat
29.1
|
-
No YoY
|
-1538.9%
-152.4
YoY
|
|
OPTN
OptiNose, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
OTRKP
Ontrak, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
PAVMZ
PAVmed Inc. - Series Z
|
-
|
Composite
43.8
Moat
14.6
|
3.55
+3.1
YoY
|
-301.3%
-286.5
YoY
|
|
-
|
Composite
47.7
Moat
37.8
|
10.97
-8.7
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
PIIIW
P3 Health Partners Inc.
|
-
|
Composite
26.1
Moat
33.5
|
3.29
-0.9
YoY
|
-18.5%
+2.3
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
PRENW
Prenetics Global Limited
|
-
|
Composite
41.0
Moat
50.0
|
34.82
+8.7
YoY
|
-41.3%
-38.9
YoY
|
|
PROC
Procaps Group, S.A.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
PRTG
Portage Biotech Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
42.5
Moat
26.2
|
5.23
-7.9
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
QSIAW
Quantum-Si incorporated
|
-
|
Composite
41.9
Moat
47.3
|
20.64
-8.0
YoY
|
-40.0%
-4.5
YoY
|
|
-
|
Composite
48.6
Moat
25.3
|
15.53
+11.3
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
45.6
Moat
44.7
|
27.08
-22.2
YoY
|
-42.1%
-34.8
YoY
|
|
|
-
|
Composite
51.2
Moat
56.7
|
-
No YoY
|
-1.4%
+0.7
YoY
|
|
|
-
|
Composite
46.8
Moat
15.9
|
7.04
+2.2
YoY
|
-
No YoY
|
|
|
-
|
Composite
56.2
Moat
75.8
|
25.89
+18.6
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
46.7
Moat
30.8
|
20.54
+11.3
YoY
|
-12.3%
+4.3
YoY
|
|
|
SCLXW
Scilex Holding Company
|
-
|
Composite
26.1
Moat
36.4
|
2.27
+1.0
YoY
|
-9.0%
-7.4
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
SHLT
SHL Telemedicine Ltd
|
-
|
Composite
35.5
Moat
27.3
|
-
No YoY
|
-47.2%
-31.4
YoY
|
|
SLRN
ACELYRIN, INC.
|
-
|
Composite
38.7
Moat
62.8
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
40.0
Moat
34.7
|
6.64
+4.9
YoY
|
-
No YoY
|
|
|
-
|
Composite
53.5
Moat
68.8
|
-
No YoY
|
37.2%
+3.5
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
SRDX
Surmodics, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
SRZNW
Surrozen, Inc. Warrant
|
-
|
Composite
45.2
Moat
55.6
|
35.41
+11.9
YoY
|
-12.1%
-9.7
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
41.0
Moat
26.0
|
-
No YoY
|
-44.9%
+42.1
YoY
|
|
|
-
|
Composite
49.2
Moat
45.8
|
23.22
-50.0
YoY
|
-2.1%
+0.6
YoY
|
|
|
-
|
Composite
34.0
Moat
19.1
|
11.34
+9.3
YoY
|
-65.1%
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
52.8
Moat
52.2
|
-
No YoY
|
-3.1%
+0.5
YoY
|
|
|
-
|
Composite
45.0
Moat
79.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
52.1
Moat
65.3
|
13.62
+11.1
YoY
|
-59.7%
-58.5
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
33.1
Moat
36.3
|
16.38
-6.1
YoY
|
-7.2%
+8.1
YoY
|
|
|
TRML
Tourmaline Bio, Inc.
|
-
|
Composite
45.1
Moat
68.7
|
-
No YoY
|
-
No YoY
|
|
TRVN
Trevena, Inc.
|
-
|
Composite
37.4
Moat
34.9
|
11.98
+3.0
YoY
|
-11.3%
-146.2
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
TSVT
2seventy bio, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
42.3
Moat
56.5
|
1.28
-0.3
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
44.3
Moat
30.5
|
16.15
-14.7
YoY
|
-
No YoY
|
|
|
VRNA
Verona Pharma plc
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
WGSWW
GeneDx Holdings Corp.
|
-
|
Composite
47.4
Moat
55.9
|
59.45
+50.8
YoY
|
-3.1%
+4.5
YoY
|
|
-
|
Composite
67.1
Moat
82.5
|
91.81
-9.6
YoY
|
97.6%
+101.5
YoY
|
|
|
-
|
Composite
67.3
Moat
82.5
|
91.81
-9.6
YoY
|
97.6%
+101.5
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
ZIMV
ZimVie Inc.
|
-
|
Composite
54.6
Moat
56.9
|
-
No YoY
|
-4.6%
+2.2
YoY
|
|
ZOM
Zomedica Corp.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
ZYXI
Zynex, Inc.
|
-
|
Composite
24.4
Moat
57.2
|
-
No YoY
|
3.1%
-2.7
YoY
|
Sector benchmarks show the distribution of key financial metrics across companies in Healthcare. Use them to contextualise individual company figures against the sector norm. The outer chart band shows the broader distribution, the middle band highlights the typical range, and the markers help separate the median from the average.